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Abstract      1 
This study was designed to investigate the potential contribution of bioactive peptides to the 2 
biological activities related to the consumption of p rk, beef, chicken and turkey meat following  3 
vitro gastro-intestinal digestion. After extraction of the peptidic fractions from digested samples, the 4 
bioactivities were evaluated by in vitro antioxidant activity as well as angiotensin-converting 5 
enzyme (ACE) and dipeptidyl peptidase-IV (DPP-IV) inhibition assays. Pork and turkey meat 6 
appeared to be the best sources of antioxidant peptides. Pork was found to be the best source of 7 
DPP-IV-inhibitory peptides whereas chicken meat supplied peptides with the highest ACE-8 
inhibitory activity. The comprehensive analysis of the peptidomic profile of digested samples was 9 
performed by nano-LC-ESI-QTOF MS/MS analysis. A total of 217, 214, 257 and 248 peptides 10 
were identified in digested pork, beef, chicken andturkey meat, respectively. Chicken and turkey 11 
meat showed the highest similarity in peptide sequences with 202 common peptides. Sixty-two 12 
peptides matched with sequences with previously demonstrated biological activity. In particular, 35 13 
peptides showed ACE-inhibitory activity and 23 DPP-IV inhibitory activity. Twenty-two bioactive 14 
peptides were commonly released from the different types of meat. The relative amount of 15 
identified bioactive peptides were positively correlat d to the biological activities of the different 16 
digested meats. 17 
Keywords: Bioactive peptides; nano-LC-ESI-QTOF MS; peptidomic; protein digestion 18 
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Biological significance 19 
The present study describes for the first time a comprehensive peptide profile of four types of meat 20 
after in vitro gastro-intestinal digestion. The peptide inventory was used to identify 62 bioactive 21 
peptides with ACE- and DPPIV-inhibitory and antioxidant activities. The bioactivity analysis 22 
revealed interesting and significant differences betwe n the studied meats. The originality of this 23 
work lay in the description of intrinsic differences in physiological functions after the ingestion of 24 
meat proteins from different species. In a context in which the current research scene relates meat 25 
consumption to the onset of chronic pathologies, thi  peptide profiling and bioactivity analysis shed 26 
light on the possible health benefits of peptides released from meat proteins. In fact, this paper 27 
represents a sort of detailed peptide list that mayhelp to predict which peptides could be generated 28 
after meat intake and detectable at gastro-intestinal level. It also provides a thorough investigation 29 
of novel biological activities associated to meat protein hydrolysates, giving a new positive aspect 30 
to meat consumption.   31 
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1. Introduction 32 
Meat is considered the best dietary source of high quality proteins due to their balanced 33 
composition in essential amino acids and their high di estibility. In addition to their nutritional 34 
value, meat proteins have encrypted in their sequence bioactive peptides, which can be released 35 
through enzymatic hydrolysis [1,2].  36 
Bioactive peptides have been defined as short protein fragments that may have a positive impact on 37 
human health [3]. These peptides are inactive within t e sequence of the parent protein and can be 38 
released following enzymatic hydrolysis such as in the gastro-intestinal tract or during food 39 
processing [4,5]. The beneficial health effects of bi active peptides include antimicrobial, 40 
antioxidative, dipeptidyl peptidase-IV (DPP-IV) and angiotensin-converting enzyme (ACE) 41 
inhibition, antihypertensive and immunomodulatory activities [3,5].  42 
ACE is an enzyme belonging to the dipeptidyl carboxypeptidase family that catalyses the hydrolysis 43 
in vivo of the plasmatic peptide angiotensin I in the potent vasoconstrictor angiotensin II. Inhibition 44 
of ACE plays an important role in the regulation of blood pressure, and ACE-inhibitory peptides are 45 
considered a source of health-enhancing compounds of paramount interest for the treatment of 46 
cardiovascular and related diseases [6].  47 
DPP-IV is a brush-border membrane-bound prolyl-dipeptidyl peptidase involved in the hydrolysis 48 
in vivo of incretins, which are peptidic gut hormones able to stimulate insulin secretion and 49 
pancreatic β-cell-proliferation. DPP-IV inhibitors reduce DPP-IV activity and can be useful in the 50 
management of type 2 diabetes by increasing the lifetime of incretins [7]. 51 
Furthermore, antioxidant peptides are particularly interesting because they can potentially prevent 52 
or delay oxidative stress associated chronic diseases, especially in the gastro-intestinal tract where 53 
they are released from the parent proteins [8]. 54 
Numerous studies were performed on bioactive peptids derived from animal proteins. Most of 55 
them focused on milk proteins, which appear to be proteins with high functional potential [9]. 56 
Bioactive peptides have been also isolated from meat using bacterial, animal and plant proteases [1, 57 
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10]. However, there is a considerable lack of information regarding the peptides released after in 58 
vitro digestion of cooked meat since only a few studies have been designed to fill this gap [11-14]. 59 
Sangsawad et al. [11] identified three novel ACE-inhibitory peptides released from cooked chicken 60 
breast after in vitro gastro-intestinal digestion (KPLLCS, ELFTT and KPLL). Whereas, Zhu et al. 61 
[12] characterized for their antioxidant properties s ven peptides released after in vitro gastro-62 
intestinal digestion of dry-cured ham. In another study, Escudero et al. [14] identified two ACE-63 
inhibitory peptides released from titin during in vitro gastro-intestinal digestion of raw pork. These 64 
peptides also showed anti-hypertensive activity n vivo [15]. Nevertheless, these studies were based 65 
on simplified digestive models and not on the harmonized basic static in vitro digestive model. 66 
Therefore, with the aim to more closely simulate th in vivo human digestive conditions, we applied 67 
in this study, the harmonized basic static in vitro protocol developed within the COST action 68 
INFOGEST [16]. Despite its obvious limitation (in vitro static model vs in vivo dynamic digestion), 69 
the harmonized INFOGEST in vitro digestion protocol is suitable for the study of digestion of 70 
protein-rich food due to its similarity with in vivo digestion [17]. 71 
Therefore, the present study was designed to evaluate and compare in vitro digestibility and 72 
biological activities (antioxidant, ACE-inhibitory and DPP-IV-inhibitory activities) of cooked pork, 73 
beef, chicken and turkey meats subjected to the INFOGEST harmonized basic static in vitro 74 
digestive model. After that, the peptidomic profiles of in vitro digested meats were determined by 75 
means of high-resolution mass spectrometry in order to correlate the possible differences in 76 
biological activities with the types and the relative amount of released bioactive peptides.77 
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2. Materials and methods 78 
2.1. Materials 79 
All MS/MS reagents were from Bio-Rad (Hercules, CA, U.S.A.), whereas the chemicals and 80 
enzymes for the digestion procedure, ACE and DPP-IV assays, antioxidant activity measurements 81 
and degree of hydrolysis determination were purchased from Sigma-Aldrich (Milan, Italy). Amicon 82 
Ultra-4 regenerated cellulose filters with a molecuar weight cut-off of 3 kDa were supplied by 83 
Millipore (Milan, Italy). Beef longissimus dorsi, pork longissimus dorsi, chicken pectoralis major 84 
and turkey pectoralis major were purchased in a local supermarket (Reggio Emilia, Italy). All the 85 
other reagents were from Carlo Erba (Milan, Italy).  86 
 87 
2.2. In vitro gastro-intestinal digestion of beef, chicken, pork and turkey meat using the harmonized 88 
protocol and preparation of the peptidic fractions 89 
Meat (average size of 10 × 15 × 0.4 cm) was cooked n a grill at 140°C for 5 min until completely 90 
cooked. After cooking, the meat was cooled on ice and stored at −80°C overnight. The frozen meat 91 
was then homogenized in a laboratory blender and divi ed in portions of 5 g [18]. Grilled and 92 
homogenized meat was in vitro digested following the protocol previously developed within the 93 
COST Action INFOGEST with modifications [16]. Briefly, salivary phase of digestion was 94 
mimicked by adding 5 mL of the simulated salivary fluid and 150 U/mL of porcine α-amylase to 5 95 
g of homogenized meat. After 5 min at 37°C, the gastric digestion step was carried out by adding 96 
10 mL of simulated gastric fluid (pH 2.0; porcine ppsin activity of 2000 U/mL of digesta) to the 97 
bolus. After 2 h of incubation at 37°C, the final intestinal step was carried out by adding 15 mL of 98 
simulated intestinal fluid containing pancreatin (100 U trypsin activity/mL of digesta) and bile 99 
(10 mmol/L in the total digesta). Samples were incubated at 37°C for a further 2 h. The simulated 100 
fluids were prepared according to the procedure described in the harmonized protocol [16].  101 
For each digestion, aliquots were taken after 0 and 5 minutes of salivary digestion, after 30, 60, 90 102 
and 120 minutes of gastric digestion and after 30, 60, 90 and 120 minutes of intestinal digestion 103 
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(Table 1). All samples were immediately cooled on ice and frozen at -80°C. One additional aliquot 104 
was taken after 120 minutes of intestinal digestion and immediately used for the preparation of the 105 
peptidic fractions. Low molecular weight peptides were extracted by ultrafiltration (cut-off 3 kDa) 106 
from the post-pancreatic digested samples as describ d by Tagliazucchi et al. [19]. The peptide 107 
content in the peptidic fraction was determined by using the TNBS method as described  in section 108 
2.3 and expressing the results as mg of leucine equivalent/mL. Peptidic fractions were then frozen 109 
at –80°C for biological activities analysis. 110 
A control digestion, which included only the gastro-intestinal juices and enzymes, and water in 111 
place of meat, was carried out to evaluate the possible impact of the digestive enzymes in the 112 
subsequent analysis. In addition, digestions of the diff rent types of meat without digestive enzymes 113 
were performed to discern the effects due to the presence of enzymes from those caused by the 114 
chemical condition in the assay. Samples were treated exactly as described above.  115 
Meat and control digestions were performed in triplicate. 116 
 117 
2.3. Assessment of protein hydrolysis during the dig st on of beef, chicken, pork and turkey meat 118 
Protein hydrolysis during the in vitro digestion was followed by measuring the amount of released 119 
amino groups using the 2,4,6-trinitrobenzenesulfonic acid (TNBS) assay and leucine as standard 120 
[20]. The obtained raw data were corrected by the contribution of the control digestion and 121 
normalized respect to the initial content in proteins of the different meats. Protein content of the 122 
different meat samples was determined by Kjeldahl method [21]. 123 
Data are expressed as mmol leucine equivalent/g meat proteins. 124 
Three analytical replicates were run for each sample in all the assays. 125 
 126 
2.4. Biological activities analysis of the peptidic fractions from digested beef, chicken, pork and 127 
turkey meat 128 
2.4.1. Antioxidant activities analysis 129 
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The antioxidant properties of the peptidic fractions from digested meat were detailed by using three 130 
different assays. Total antioxidant activity was determined using the 2,2′-azino-bis(3-131 
ethylbenzothiazoline-6-sulphonic acid (ABTS) method as described by Re et al. [22]. The capacity 132 
to scavenge hydroxyl radicals was evaluated according to Martini et al. [23]. The obtained raw data 133 
were corrected by the contribution of the control digestion and expressed as μmol trolox 134 
equivalent/g of peptides. 135 
The ability to inhibit lipid peroxidation was tested using a linoleic acid emulsion system as detailed 136 
in Tagliazucchi et al. [9]. The lipid peroxidation inhibitory activity of the samples was expressed as 137 
percentage of inhibition with respect to a control reaction carried out in presence of the peptidic 138 
fraction of the control digestion. 139 
Three analytical replicates were run for each sample in all the assays. 140 
 141 
2.4.2. Measurements of angiotensin-converting enzyme (ACE)-inhibitory and dipeptidyl peptidase 142 
IV (DPP-IV)-inhibitory activities 143 
ACE-inhibitory activity was measured by the spectroph tometric assay of Ronca-Testoni [24] using 144 
the tripeptide N-[3-(2-furyl)acryloyl]-L-phenylalanyl-glycyl-glycine (FAPGG) as substrate. 145 
The enzyme DPP-IV was extracted from rat intestinal acetone powder and assayed as reported in 146 
Tagliazucchi et al. [9]. The dipeptide glycine-proline-p-nitroanilide (Gly-Pro-pNA) was used as 147 
substrate. The concentration of peptides required to cause 50% inhibition of the ACE or DPP-IV 148 
activity (IC50) was determined by plotting the percentage of ACE or DPP-IV inhibition as a 149 
function of final sample concentration (base-10 logarithm). IC50 values were expressed as mg of 150 
peptides/mL. Data were corrected for the contribution of the control digestion. 151 




2.5. Analysis of the peptidomic profile of peptidic fractions of beef, pork, chicken and turkey meat 154 
by nanoflow liquid chromatography accurate mass quadr pole time-of-flight mass spectrometry 155 
with electrospray ionization (LC-ESI-QTOF MS)  156 
The peptidic fractions from digested pork, beef, chicken and turkey meats as well as from control 157 
digestion were subjected to QTOF MS/MS analysis for peptide identification. Nano LC/MS and 158 
tandem MS experiments were performed on a 1200 Series Liquid Chromatographic two-159 
dimensional system coupled to a 6520 Accurate-Mass Q-TOF LC/MS via a Chip Cube Interface 160 
(Agilent Technologies, Santa Clara, CA, USA). Chromatographic separation was performed on a 161 
ProtID-Chip-43(II) including a 4mm 40 nL enrichment column and a 43mm × 75μm analytical 162 
column, both packed with a Zorbax 300SB 5 μm C18 phase (Agilent Technologies).  163 
For peptide identification, a non-targeted approach was applied as reported by Tagliazucchi et al. 164 
[9]. The mass spectrometer was tuned, calibrated and set with the same parameters as reported by 165 
Dei Più et al. [25]. For peptide identification and sequencing, MS/MS spectra were converted to 166 
.mgf and were then searched against the Swiss-Prot database (SwissProt 2016_03 version) using 167 
Protein Prospector (http://prospector.ucsf.edu) and MASCOT (Matrix Science, Boston, MA, USA) 168 
protein identification softwares. The taxonomical identifiers were: Sus scrofa (1416 entries) in the 169 
case of pork, Bos taurus (5998 entries) in the case of beef and Chordata (84573 entries) in the case 170 
of chicken and turkey meat. The following parameters were considered: enzyme, none; number of 171 
missed cleavage allowed, none; peptide mass toleranc , ± 20 ppm; fragment mass tolerance, ± 0.08 172 
Da; variable modifications, oxidation (M) and phosphorylation (ST); maximal number of PTMs 173 
permitted in a single peptide, 4. Only peptides with a best expected value lower than 0.05 that 174 
corresponded to P<0.01 and ion scores > 20 to ensure false-positive discovery rates of < 1% of the 175 
peptides were considered. Short peptides (from 2 to 5 residues) were identified through a de novo 176 
peptide sequencing approach performed by Pepnovo software 177 
(http://proteomics.ucsd.edu/ProteoSAFe/) using the same parameters as reported above. The 178 




2.6. Identification of bioactive peptides 181 
The peptides identified in digested meat samples were investigated in relation to bioactive peptides 182 
previously identified in the literature using the BIOPEP, the BioPep DB (BioPep Database) and the 183 
AHTPDB (anti-hypertensive peptide database) databases [26-28]. Only peptides with 100% 184 
homology to known functional peptides were considere  as bioactive peptides. The relative amount 185 
of the bioactive peptides was estimated by integrating the area under the peak (AUP). AUP was 186 
measured from the extracted ion chromatograms (EIC) obtained for each peptide and normalized to 187 
the peptide content of the respective peptidic fraction. The peptide content was determined by using 188 
the TNBS method as described in section 2.3 and expressing the results as mg of leucine 189 
equivalent/mL. The areas under the peak (AUP) of the peptides with the highest DPP-IV- and ACE-190 
inhibitory activities (i.e. peptides with IC50 ≤ 100 μmol/L) and antioxidant amino acids/peptides 191 
was used for principal component analysis (PCA) (see supplementary Table S1). This approach 192 
could help to describe the variance (information) in a set of multivariate data, where the original 193 
variables (here: peptides) may be expressed as linear combination of orthogonal principal 194 
components (PCs). 195 
 196 
2.7. Statistical analysis   197 
All data are presented as mean ± standard deviation (SD) for three replicates for each prepared 198 
sample. Univariate analysis of variance (ANOVA) with Tukey post-hoc test was applied using 199 
GraphPad Prism 6.0 (GraphPad Software, San Diego, CA, USA). The differences were considered 200 
significant with P <0.05. Principal component analysis (PCA) was performed using the software 201 
package Solo (v 8.6.1, 2018 Eigenvector Research, In . Manson, WA, USA), considering analytical 202 
properties as variables.   203 
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3. Results and discussion 204 
 205 
3.1 Comparison between the digestibility of beef, chicken, pork and turkey meat proteins 206 
The degradation of meat proteins by gastro-intestinal proteolytic enzymes was compared by 207 
measuring the amount of released free amino groups using TNBS assay. Data reported in F gure 1 208 
were normalized respect to the initial protein content of the different studied meats and expressed as 209 
mmol of leucine equivalent per g of protein. There were significant differences in protein 210 
digestibility among the four analyzed meat products (P< 0.05, Figure 1). Gastric digestion had little 211 
effect on protein digestibility with the majority of hydrolysis occurring in the first 30 min of 212 
incubation. At the end of the gastric digestion no significant statistical differences were observed 213 
between the different types of meat (P>0.05; Figure 1). The transition from gastric to pancreatic 214 
environment determined a significant increase in the amount of free amino groups in all the 215 
digested meat products (P < 0.05; Figure 1). At the end of the digestion, beef showed a significant 216 
higher amount of released amino groups compared to pork and turkey meat (P<0.05). No 217 
significant differences were found between the amount f free amino groups released from beef and 218 
chicken meat (P>0.05) nor between pork and chicken meat (P>0.05;  Figure 1). Chicken meat 219 
digestion released a higher amount of amino groups compared to pork digestion although the results 220 
were not significantly different (P>0.05).  Indeed, pork and chicken meat digestion result d in 221 
greater hydrolysis than turkey meat (P<0.05). These results showed that gastric and duodenal 222 
enzymes degraded beef and chicken proteins faster and more efficiently than pork and, especially, 223 
turkey proteins. When the amount of released free amino groups was quantified in the digestions 224 
with meat but without digestive enzymes, we did not find significant differences in the values 225 
during the entire in vitro digestion for each type of meat. 226 
In a previous study, Wen et al. [29] found that chicken meat and pork had higher digestibility after 227 
peptic digestion than beef, whereas they did not find any differences between the three types of 228 
meat after peptic/tryptic digestion. In another study, Luo et al. [30] found no significant differences 229 
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between the in vitro digestibility of minced beef, pork and chicken. Differences with our results are 230 
plausibly related to the different in vitro digestive models used. Indeed, meat protein digestibility is 231 
highly dependent on the muscle type and on the method of processing [31-34].  The poor efficiency 232 
of hydrolysis observed during gastric digestion with pepsin may be a consequence of the high 233 
cooking temperature applied in this study (140°C). Cooking temperature over 100°C may promote 234 
protein aggregation and a decrease of protein hydrolysis by pepsin [32,33]. 235 
 236 
3.2 Antioxidant properties of the post-pancreatic peptidic fractions 237 
The antioxidant properties of the peptidic fractions of the different digested meats were thoroughly 238 
characterized. The ability to scavenge ABTS and hydroxyl radicals as well as the ability to inhibit 239 
lipid peroxidation were assessed (Table 2). The highest amount of released peptides after pancre tic 240 
digestion was found in beef, whereas pork and turkey digestion resulted in a significantly lower 241 
release of peptides (P<0.05). The peptidic fractions from the digestions carried out in absence of 242 
the digestive enzymes showed the presence of some TNBS-reactive material (supposedly 243 
peptides/amino acids generated during meat treatments), which, however, was always below the 244 
10.5% of the values obtained after the complete digst on. The highest value was found for chicken 245 
(2.00 ± 0.12 mg/mL), followed by turkey (1.83 ± 0.08 mg/mL), pork (1.44 ± 0.05 mg/mL) and beef 246 
(1.22 ± 0.07 mg/mL). 247 
Data were normalized for the peptide content in order to compare the antioxidant properties of the 248 
peptidic fractions of the different digested meats. ABTS radical scavenging activity of the peptidic 249 
fractions of beef, chicken and turkey was not signif cantly different (P>0.05), whereas digested 250 
pork peptidic fraction showed the highest ABTS radic l scavenging activity (Table 2). Peptidic 251 
fraction from digested pork was also the most active against hydroxyl radical whereas the peptidic 252 
fraction from chicken meat was not active (Table 2). The highest anti-peroxidative activity against 253 
linoleic acid auto-oxidation was found for the peptidic fraction of turkey meat followed by pork. No 254 
significant differences were found between the anti-peroxidative activity of turkey meat and pork 255 
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peptidic fractions (P>0.05). Whereas, chicken meat peptidic fraction displayed significantly lower 256 
activity (P<0.05). Finally, beef peptidic fraction exhibited the lowest anti-peroxidative activity 257 
(P<0.05). No activities were detected in the peptidic fra tions from the digestions without enzymes 258 
in all the antioxidant activity assays. 259 
Previous studies suggested that cooking procedure may have an impact on meat antioxidant 260 
properties [35-38]. Cooking at low temperature (<100°C) did not affected the antioxidant properties 261 
of meat peptidic fractions [35-37] whereas cooking at a higher temperature (180°C) led to an 262 
increase in meat antioxidant activity [38]. In fact, Serpen and co-workers [38] found that the 263 
antioxidant activity of beef, pork and chicken meat increased on heating (oven at 180°C) at the 264 
beginning of the cooking time as consequence of protein denaturation and exposure of reactive 265 
protein sites. After that, the antioxidant activity s arted to decrease (degradation of endogenous 266 
antioxidants). Although, at the longest heating time a further increase in antioxidant activity was 267 
seen. This increase was mainly attributed to the formation of Maillard reaction products with 268 
antioxidant activity [38]. Moreover, as previously reported, in vitro digestion had a greater impact 269 
than cooking on the antioxidant activity of meat samples [35-37]. 270 
Anyway, due to the extraction procedure we can not exclude that the antioxidant properties of the 271 
meat peptidic fractions were partly due to the presence of endogenous antioxidants not degraded by 272 
the cooking treatment or to the formation during cooking of new antioxidant molecules (i.e. 273 
Maillard reaction products). 274 
 275 
3.3 ACE-inhibitory and DPP-IV-inhibitory activities of the post-pancreatic peptidic fractions 276 
The post-pancreatic peptidic fractions obtained after digestion of the different types of meat were 277 
analysed for their ACE-inhibitory activity. The calu ated IC50 values (defined as the peptide 278 
concentration required to inhibit 50% of the ACE activity) ranged from 81.2 ± 4.4 to 238.0 ± 14.2 279 
μg of peptides/mL (Figure 2A). The hydrolysates produced by the action of digest v  enzymes on 280 
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chicken meat exhibited the lowest IC50 value, signifying the highest ACE-inhibitory activi y, 281 
whereas turkey meat peptidic fraction displayed the lowest inhibitory activity (Figure 2A).  282 
Peptidic fractions from pork and beef showed medium inhibitor potency and their IC50 values were 283 
not significantly different (P>0.05). 284 
Previous studies have already reported the ACE-inhibitory activity of digested fractions obtained 285 
from cooked chicken breast and thigh as well as from aw and cooked pork, and cooked beef 286 
[11,39,40]. Unfortunately, the IC50 values were not calculated in these studies. Furthermore, the 287 
applied in vitro digestion models were different from the conditions of the harmonized digestive 288 
system developed within the COST action INFOGEST, which more accurately reflects the in vivo 289 
physiological conditions [16]. Based on these considerations, the comparison of the data with the 290 
previous studies was not possible. However, the digstion of camel, cow, goat and sheep milk, 291 
using the same harmonized in vitro model, resulted in an IC50 value higher than those found in this 292 
study [9]. Previous studies examined the effect of co king and in vitro digestion on the ACE-293 
inhibitory activity of meat peptidic fractions. Despite a small increase in the inhibitory activity after 294 
cooking, presumably due to degradation of proteins, the highest rise was found after in vitro 295 
digestion [35,36,39]. 296 
DPP-IV-inhibitory activity was also demonstrated for the post-pancreatic peptidic fractions of the 297 
different types of meat (Figure 2B). A dose dependent inhibition was observed for all digests but 298 
some differences were noted. Pork post-pancreatic peptidic fraction had the lowest IC50 value 299 
against DPP-IV (1.88 ± 0.10 mg peptides/mL), which means the highest inhibitory activity. The 300 
other digested meat samples showed higher IC50 values against DPP-IV ranging from 2.24 to 2.71 301 
mg peptides/mL. Digested chicken meat displayed a significant lower inhibitory activity than 302 
digested turkey meat (P<0.05). 303 
No data are available in literature about the DPP-IV-inhibitory activity of hydrolysates generated 304 
thorough in vitro gastro-intestinal digestion of meat. However, two different in silico studies 305 
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suggested the possible release of DPP-IV-inhibitory peptides from bovine and porcine meat proteins 306 
[41,42]. 307 
Finally, the peptidic fractions from the digestion experiments performed in absence of digestive 308 
enzymes did not showed any ACE- or DPP-IV-inhibitory activities. 309 
 310 
3.4. Peptidomic profile of in vitro digested beef, chicken, pork and turkey meat peptidic fractions 311 
and identification of antioxidant, ACE-inhibitory and DPP-IV-inhibitory peptides 312 
The peptides composition of the peptidic fractions from four meat products after in vitro gastro-313 
intestinal digestion was outlined through a nano-LC–MS/MS QTOF mass spectrometer. The 314 
complete list of the identified peptides is detailed in supplementary Tables S2-S5. Chicken and 315 
turkey meat gave the greatest number of peptides (257 and 248, respectively) whereas pork and beef 316 
had a smaller number of peptides (217 and 214, respectively). The molecular weight of the 317 
identified peptides ranged from 188 to 2518 Da. Figure 3 shows that the majority of the peptides 318 
identified after in vitro digestion had a molecular weight lower than 500 Da (from 48% to 40% in 319 
pork and beef, respectively) for all the meat samples. Less than 10% of the identified peptides 320 
obtained after meat digestion displayed a molecular weight higher than 1000 Da with the exception 321 
of the digested beef (14.2% of the identified peptides). Sequence matching indicates that the 322 
majority of the peptides (especially the shorter ones) were included in the sequence of various 323 
muscle proteins (37.4, 33.0, 30.7 and 34.3% in pork, beef, chicken and turkey meat, respectively). 324 
Digested chicken and turkey meat contained the highest number of peptides not assigned to a 325 
specific muscle protein (14.4 and 12.9%, respectively). Whereas, the amount of non assigned 326 
peptides was 8.9 and 6.4% in digested pork and beef, respectively. The highest number of not 327 
assigned peptides in digested chicken and turkey meat samples may be due to the lower number of 328 
sequenced proteins in these two organisms. 329 
Myofibrillar proteins, particularly actin, titin and myosin were the main sources of peptides in all 330 
the in vitro digested meat samples (Figure 4). Sarcoplasmic proteins (among others 331 
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glyceraldehyde-3-phosphate dehydrogenase, creatine kinase and enolase) gave lower amounts of 332 
peptides respect to myofibrillar proteins (Figure 4). In accordance, previous studies found that 333 
myofibrillar proteins were hydrolysed more easily than sarcoplasmic or mitochondrial proteins 334 
during in vitro digestion [29,43,44]. Furthermore, the digestion of meat proteins by gastro-intestinal 335 
proteases is affected by the heat treatments such as ooking times and temperatures and muscle 336 
types [29,43,44]. For example, Sayd and co-workers [44] found that sarcoplasmic proteins were 337 
mainly cleaved when meat was cooked at low temperature whereas cooking at high temperature 338 
decreased their hydrolysis rate. On the contrary, collagen was better cleaved when meat was cooked 339 
at high temperature. Moreover, myofibrillar proteins were hydrolysed preferentially in the small 340 
intestinal compartment and their hydrolysis was not affected by cooking temperature.  341 
In addition (supplementary Table S6), 8 amino acids were also identified, 7 of them being essential 342 
amino acids (W, L/I, T, V, K, R and F).  343 
The Venn diagram (Figure 5A) showed that 48, 58, 34, and 31 peptides were specific for in vitro 344 
digested pork, beef, chicken and turkey meat, respectively. A total of 74 identified peptides were 345 
common to all four digested meats. Chicken and turkey meat showed the highest similarity in 346 
peptide sequences with 202 common peptides. Among them, 102 were also in common with pork 347 
and 92 with beef. Eighty-two peptides were found only i  chicken and turkey digested meat. 348 
The Venn diagram (Figure 5B) also showed that 22 identified bioactive peptides w re common for 349 
all four digested meats. Pork and beef gave the highest number of unique bioactive peptides (4 350 
specific peptides for each species) and showed the highest similarity in bioactive peptide sequences 351 
with 33 common peptides. 352 
Tables 3-5 display the identified peptides with previously reported antioxidant, ACE-inhibitory and 353 
DPP-IV-inhibitory activities. The majority of the identified bioactive peptides were di- or tri-354 
peptides arising from various meat proteins. Four actin-derived peptides, with previously reported 355 
ACE-inhibitory activity were also identified. Some of the detected peptides were multi-functional 356 
such as VW and LW, which showed antioxidant as wellas ACE- and DPP-IV-inhibitory activities. 357 
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An additional five peptides (WL, WM, FP, AV and IR) displayed both ACE- and DPP-IV-358 
inhibitory activities. 359 
Five amino acids and four peptides with previously reported antioxidant properties were identified 360 
in the peptidic fraction of digested meat (Table 3). One peptide (LW) and one amino acid (F) were 361 
found in the peptidic fractions of all the digested meats whereas the others antioxidant peptides and 362 
amino acids were found only in specific fractions. Pork and turkey meat peptidic fractions, which 363 
showed the best antioxidant properties, were the only ones containing the potent antioxidant amino 364 
acid Y (Table 3). In general, amino acids had been previously suggested as the major contributors 365 
to the antioxidant activity of digested milk from various species [8,9,45]. Essentially, the presence 366 
of at least one amino acid with antioxidant properties in the peptide sequence seems to be crucial 367 
[46]. As reported in the on-line supplementary Tables S2-S5, several peptides containing tyrosine, 368 
tryptophan and/or phenylalanine in their sequence were found in the digested meat, which can 369 
contribute to the radical scavenging and anti-peroxidative activities of the peptidic fractions. 370 
A total of 35 peptides presented ACE-inhibitory activity (Table 4). The actin-derived peptides 371 
VFPS, previously isolated from wheat germ hydrolysate, showed very low IC50 value and could be 372 
the primary contributors to the ACE-inhibitory activity of the digested meat [47]. Some of the 373 
identified peptides have proven anti-hypertensive activity in vivo. For example, the dipeptides VW, 374 
IW, VF, LW and FP, the tripeptide LLF as well as the actin-derived tripeptides AVF were found to 375 
be able to decrease systolic and diastolic blood pressure in spontaneously hypertensive rats [48]. 376 
Some shorter peptides with very low IC50 values against ACE were found to be bioavailable in 377 
human subjects [49-51]. The peptides VF, IW, LW andIY have been detected in plasma of human 378 
volunteers after consumption of dairy products [49,50]. These peptides were not present in the 379 
given beverage suggesting that they were generated during gastro-intestinal digestion of milk 380 
proteins and absorbed as such. In another study, the single oral administration to human volunteers 381 
of the dipeptides IW and WL resulted in a significant increase in their plasmatic concentration [51]. 382 
Indeed, oral administration of IW and WL resulted in inhibition of human plasma ACE activity 383 
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supporting the assumed bioactive potential of these p ptides deduced from in vitro measurements. 384 
Altogether, our results suggest that meat may be a good source of potentially bioavailable ACE-385 
inhibitory and anti-hypertensive peptides.   386 
Finally, 23 peptides with previously demonstrated DPP-IV-inhibitory activity were identified in the 387 
peptidic fractions of digested meat (Table 5). The tripeptide IPI (also known as Diprotin A) showed 388 
very low IC50 value against DPP-IV and could be the primary contributor to the DPP-IV-inhibitory 389 
activity of the digested meat (Table 5). Despite their obvious role in the management of ype 2 390 
diabetes, DPP-IV inhibitors may also decrease the intestinal catabolism of others bioactive peptides 391 
containing the sequence X-P at the N-terminus enhancing the absorption of the latter. 392 
PCA revealed that three principal components explained 100% of total variance. The cumulative 393 
percentage of the total variance explained by the first two components was 87.46%. A third 394 
component was useful in obtaining a comprehensive explanation of the relationships between meats, 395 
peptides and bioactivities. The two bi-dimensional plots are reported in Figure 6. The PC1xPC2 396 
biplot (Figure 6A) shows a clear separation of the meats on the first component. In order to 397 
understand which variables were most accountable for the obtained distribution and the correlation 398 
between peptides and meats, loadings and scores wer plotted in the bi-dimensional graphs. Pork, 399 
positively linked on PC1, split apart from the others and was more effective in antioxidant and DPP-400 
IV-inhibitory activities. As depicted by the positive loadings and positive correlation on PC1, pork 401 
was characterized by the highest content of bioactive peptides related to the activities reported above 402 
(blue and green circles). Peptides with ACE-inhibitory activity were not well separated on PC1xPC2 403 
biplot. However, a relation due to a species-specific e fect influencing the scattering of ACE-404 
inhibitory peptides could be observed. Indeed, chicken and turkey meats, negatively linked on PC1, 405 
displayed the same positive scores on PC2. However, on the third principal component (Figure 6B), 406 
we noted a clear split of chicken and turkey. This separation was due to the most effective ACE-407 
inhibitory activity of the chicken meat correlated to the high content of VW, VFPS and WL (negative 408 
loadings on PC3). Beef and pork, which were less effective in ACE-inhibitory activity than chicken 409 
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meat, also had negative scores on PC3, related to the high incidence of ACE-inhibitory peptides (red 410 
circle). 411 
 412 
4. Conclusion 413 
In the present study, we applied an integrated approach combining peptidomic techniques with in 414 
vitro bioactivity assays. The four different meats were subjected to the harmonized INFOGEST in 415 
vitro gastro-intestinal digestion protocol. Our study indicated that meat not only delivers important 416 
nutrients to humans but also provides a source of bioactive peptides such as antioxidant as well as 417 
ACE- and DPP-IV-inhibitory peptides.  418 
Despite the limited differences in protein digestibili y between the four types of tested meats, we 419 
found distinction in the peptidomic profiles after digestion. This discrepancy reflects the intrinsic 420 
differences in meat protein sequences. Moreover, thse differences may result in the variation of the 421 
biological activities among species after in vitro digestion. Pork and turkey meats appeared to be the 422 
best sources of antioxidant peptides. Pork was also found to be the best source of DPP-IV-423 
inhibitory peptides whereas chicken supplied peptids with the highest ACE-inhibitory activity. 424 
Different cooking temperatures and muscle types mayled to relevant differences in peptide 425 
composition and abundance after in vitro gastro-intestinal digestion. Such quantitative and426 
qualitative differences may have an important impact on the release of bioactive peptides and 427 
related bioactivities of digested meat. Therefore, ur results did not allow to make general 428 
conclusions and further studies about the effect of o king parameters and muscle types are 429 
warranted. 430 
However, the present study lays the groundwork to discern meat from different species in the wake 431 
of their potential biological activities and bioactive peptides profile after in vitro digestion. Indeed, 432 
this study aims to revise the concept of meat consumption, giving a new positive perspective, which 433 
has never been considered until now. However, more investigations and, especially, in vivo trials 434 
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Figure 1. Comparison between the in vitro digestibility of pork, beef, chicken and turkey meat 
proteins. Release of free amino groups during i  vitro salivary, gastric and pancreatic phases of 
digestion of pork (A), beef (B), chicken (C) and turkey (D) meat. Data were normalized with 
respect to the initial protein content of the different meats studied and expressed as mmol of leucine 
equivalent per g of protein. Values are means of three independent digestions ± standard deviation 
(SD). Different letters indicate significantly different values (P < 0.05) within the individual 
digestion. 
Figure 2. Angiotensin-converting enzyme (ACE)-inhibitory and dipeptidyl peptidase-IV 
(DPP-IV)-inhibitory activity of the peptidic fractions of digested pork, beef, chicken and 
turkey meat. ACE-inhibitory activity (A). DPP-IV inhibitory activity (B). Peptidic fractions were 
extracted by ultrafiltration (< 3 kDa) from the post-pancreatic samples of the different meats. IC50 is 
defined as the concentration of peptides required to inhibit 50% of the ACE or DPP-IV activity. 
Different letters indicate that the values are significantly different (P < 0.05). 
Figure 3. Molecular mass distribution of meat peptides in the post-pancreatic peptidic 
fractions. Data are expressed as percentage of peptides detected in the peptidic fractions obtained 
from pork (       ), beef (       ), chicken (     ) and turkey (       ) meat after in vitro gastro-intestinal 
digestion. 
Figure 4. Distribution of peptides in the meat proteins. Percentage of peptides assigned to pork 
muscle proteins identified in the post-pancreatic peptidic fractions (A). Percentage of peptides 
assigned to beef muscle proteins identified in the post-pancreatic peptidic fractions (B). Percentage 
of peptides assigned to chicken meat muscle proteins identified in the post-pancreatic peptidic 
fractions (C). Percentage of peptides assigned to turkey meat muscle proteins identified in the post-
pancreatic peptidic fractions (D). Proteins with only one identified peptide were clustered in the 
other proteins group. Numbers indicate the amount of peptides assigned to a specific protein. 
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Figure 5. Venn diagrams of peptides obtained from pork, beef, chicken and turkey meat. (A) 
Venn diagram was created with all the identified peptides released after in vitro gastro-intestinal 
digestion (see on line supplementary material Tables S2-S5 for the peptide sequences). (B) Venn 
diagram was created with only the bioactive peptides released and identified after in vitro gastro-
intestinal digestion (see Tables 3-5 for the peptide sequences and bioactivity). 
Figure 6. Distribution of peptides along principal components 1 (PC1), 2 (PC2) and 3 (PC3). 
(A) Bi-plot PC1 versus PC2. (B) Bi-plot PC1 versus PC3. Blue circles identified antioxidant amino 
acids/peptides. Red circles identified ACE-inhibitory peptides. Green circles identified DPP-IV-
inhibitory peptides. Light blue circles identified peptides with both ACE- and DPP-IV-inhibitory 
activities. Orange circles identified peptides with both ACE-inhibitory and antioxidant activities. 


































Digestion phase minutes Analysis 
Salivary phase 0 Protein hydrolysis 
 5 Protein hydrolysis 
Gastric phase 30 Protein hydrolysis 
 60 Protein hydrolysis 
 90 Protein hydrolysis 
 120 Protein hydrolysis 
Intestinal phase 30 Protein hydrolysis 
 60 Protein hydrolysis 
 90 Protein hydrolysis 
 120 
Protein hydrolysis, biological 
activities, peptidomic profile 
 
 
Table 2. Peptide content, ABTS radical scavenging activity, hydroxyl radical scavenging activity 
and lipid peroxidation inhibitory activity of peptidic fractions (< 3 kDa) obtained from beef, 
chicken, pork and turkey meat after in vitro gastro-intestinal digestion. 
 
Values represent means ± standard deviation of triplicate determination; different superscript letters within the same 
column indicate that the values are significantly different (P < 0.05). 
*% of inhibition was determined using the < 3 kDa fr ctions of the post-pancreatic sample at a concentration of 1 g/L of 
peptide 
n.a. means no activity detected 





Inhibition of lipid 
peroxidation 
 mg/mL μmol trolox/g of peptides % inhibition* 
Beef  20.71 ± 0.86a 594.9 ± 22.2a 246.6 ± 12.3a 42.1 ± 4.9a 
Chicken  19.09 ± 0.77a,b 535.2 ± 32.7a n.a. 73.0 ± 7.0b 
Pork 18.17 ± 0.61b 714.3 ± 39.9b 771.3 ± 25.4b 89.8 ± 1.5c 
Turkey 17.71 ± 0.65b 651.9 ± 24.7a.b 231.5 ± 13.0a 99.1 ± 4.6c 
Table 3. Peptides and amino acids with previously described antioxidant properties 
identified in the peptidic fractions (< 3 kDa) obtained from pork, beef, chicken and turkey 
meat after in vitro gastro-intestinal digestion. 
 
Sequence Activity Samplea Proteinb 
    T Hydroxyl radical 
scavenging 
P Various proteins 
F Hydroxyl radical 
scavenging 
Inhibition of lipid 
peroxidation 
P, B, C, T Various proteins 
R Hydroxyl radical 
scavenging 
Inhibition of lipid 
peroxidation 
P, B Various proteins 
Y ABTS radical scavenging 
Hydroxyl radical 
scavenging 





W ABTS radical scavenging 
Hydroxyl radical 
scavenging 
Inhibition of lipid 
peroxidation 
P, B Various proteins 
LH Inhibition of lipid 
peroxidation 
B Various proteins 
VW Hydroxyl radical 
scavenging 
P, C, T Various proteins 
LW Hydroxyl radical 
scavenging 
P, B, C, T Various proteins 
LWV Inhibition of lipid 
peroxidation 
B Various proteins 
aSample in which the peptide was identified (P: digested pork meat; B: digested beef meat; C: digested 
chicken meat; T: digested turkey meat)   
bPrecursor protein 
Table 4. Peptides with previously described angiotensin-converting enzyme (ACE)-
inhibitory activity identified in the peptidic fractions (< 3 kDa) obtained from pork, beef, 
chicken and turkey meat after in vitro gastro-intestinal digestion. Peptides are listed on 
the basis of their inhibitory potency. 
 
Sequence IC50a Sampleb Proteinc 
VFPS 0.5 μmol/L P, B, C, T Actin 
VW 1.1-3.3 μmol/L P, C, T Various proteins 
IW 1.5-5.6 μmol/L P, B, C, T Various proteins 
VF 9.2 μmol/L P, T Various proteins 
WL 10 μmol/L P, B, C, T Various proteins 
LVL 12 μmol/L T Various proteins 
LVE 14 μmol/L C, T Various proteins 
LW 15 μmol/L P, B, C, T Various proteins 
VIP 26 μmol/L P, B, C, T Various proteins 
LKYPI 27 μmol/L P, B Actin 
FPF 28 μmol/L B Various proteins 
LGI 29 μmol/L P, B, C, T Various proteins 
LPF 40 μmol/L P, B, C Various proteins 
IVP 50 μmol/L P Various proteins 
IL 55 μmol/L P, B, C, T Various proteins 
LLF 82 μmol/L P, B, C, T Various proteins 
WM 95 μmol/L P, C, T Various proteins 
 FIV  123 μmol/L P, B Various proteins 
LR 158 μmol/L P, B, C, T Various proteins 
FP 205 μmol/L C, T Various proteins 
ILP 270 μmol/L P, B, C, T Various proteins 
VLP 320 μmol/L P, B, C, T Various proteins 
PL 337 μmol/L P, B, C, T Various proteins 
LF 349 μmol/L P, B, C, T Various proteins 
AVF 406 μmol/L P, B, C, T Actin 
IAIP 470 μmol/L P, C, T Various proteins 
MYPGIA 641 μmol/L P, B, C, T Actin 
IR 695 μmol/L P, B, C, T Various proteins 
IF 930 μmol/L P, B, C, T Various proteins 
GLx >1000 μmol/L P Various proteins 
AV >1000 μmol/L P Various proteins 
AI >1000 μmol/L P, B Various proteins 
DL >1000 μmol/L P Various proteins 
LLG >1000 μmol/L T Various proteins 
NIIPA >1000 μmol/L P, B, C, T Glyceraldehyde-3-
phosphate 
dehydrogenase 
aIC50 is defined as the concentration of peptides required to inhibit 50% of the enzymatic activity. The 
values are from BIOPEP, BioPep DB and AHTPDB databases (Minkiewicz, Dziuba, Iwaniak, Dziuba, & 
Darewicz, 2008; Qilin et al., 2018; Kumar et al., 2015).  
bSample in which the peptide was identified (P: digested pork meat; B: digested beef meat; C: digested 
chicken meat; T: digested turkey meat) 
cPrecursor protein 
Table 5. Peptides with previously described dipeptidyl peptidase IV (DPP-IV)-inhibitory 
activity identified in the peptidic fractions (< 3 kDa) obtained from pork, beef, chicken 
and turkey meat after in vitro gastro-intestinal digestion. Peptides are listed on the basis 
of their inhibitory potency. 
 
Sequence IC50a Sampleb Proteinc 
IPI 3.5 μmol/L P, B, C, T Various proteins 
WL 44 μmol/L P, B, C, T Various proteins 
IPM 70 μmol/L P Various proteins 
VL 74 μmol/L P, C, T Various proteins 
WI 89 μmol/L P, B, C, T Various proteins 
ML 91 μmol/L P, B, C Various proteins 
IP 150 μmol/L P, B Various proteins 
LPL 241 μmol/L P, B, C, T Various proteins 
WM 243 μmol/L P, C, T Various proteins 
FP 363 μmol/L C, T Various proteins 
FL 400 μmol/L P, B, C, T Various proteins 
LP 712 μmol/L P, B Various proteins 
AL 882 μmol/L P, B Various proteins 
LW 993 μmol/L P, B, C, T Various proteins 
AV >1000 μmol/L P Various proteins 
PV >1000  μmol/L B Various proteins 
AH >1000 μmol/L P, B, T Various proteins 
VI >1000 μmol/L P, C, T Various proteins 
LV >1000 μmol/L P, C, T Various proteins 
MI >1000 μmol/L P, B, C Various proteins 
LM >1000 μmol/L P, C, T Various proteins 
 IR  >1000 μmol/L P, B, C, T Various proteins 
 VW  >1000 μmol/L P, C, T Various proteins 
aIC50 is defined as the concentration of peptides required to inhibit 50% of the enzymatic activity. The 
values are from BIOPEP, BioPep DB and AHTPDB databases (Minkiewicz, Dziuba, Iwaniak, Dziuba, & 
Darewicz, 2008; Qilin et al., 2018; Kumar et al., 2015).  
bSample in which the peptide was identified (P: digested pork meat; B: digested beef meat; C: digested 






Table S1. Relative amount of the identified bioactive peptides in the digested meat 











     Amino acids/peptides with 
antioxidant activity 
    
T 22141 n.d. n.d. n.d. 
F 145463 12134 10649 7283 
R 52153 27939 n.d. n.d. 
Y 22747 n.d. n.d. 1223 
W 37625 1981 n.d. n.d. 
LH n.d. 14254 n.d. n.d. 
LVW n.d. 9216 n.d. n.d. 
     
Peptides with ACE-inhibitory 
activitya 
    
VFPS 166103 40824 134218 86454 
IW 399508 16505 369881 382906 
VF 129551 n.d. n.d. 11908 
LVL n.d. n.d. n.d. 178887 
LVE n.d. n.d. 66093 79413 
VIP 103666 10938 138912 99629 
LKYPI 15318 11418 n.d. n.d. 
FPF n.d. 1694 n.d. n.d. 
LGI 78342 66502 59727 63778 
LPF 69576 85345 59481 n.d. 
IVP 103666 n.d. n.d. n.d. 
IL 473989 12422 444767 487243 
LLF 4259 12388 42010 25296 
WM 100591 n.d. 85094 77408 




Peptides with DPP-IV-inhibitory 
activitya 
    
IPI 217189 67675 72961 84832 
IPM 234138 n.d. n.d. n.d. 
VL 176397 136669 n.d. 171345 
WI 195071 42064 71595 160543 
     
Peptides with both ACE-
inhibitory and antioxidant 
activitiesa 
    
VW 142612 n.d. 170221 140692 
LW 132313 155788 102641 131260 
     
Peptides with both ACE- and 
DPP-IV-inhibitory activitiesa 
    
WL 195071 42063 249749 207470 





Table S2. Peptides identified in the <3 kDa permeate obtained from pork after 








Charge Proteinb Fragment 
NSLVYSNPVSSLGNPNFLPLAHP 2517.2021 2517.2174 -6.08 +3 Myocyte-specific 
enhancer factor 2C 
f(151-173) 
 
GLTGPIGPPGPSGAPGDK 1574.8326 1574.8173 9.72 +2 Collagen α-1(I) chain* f(764-781) 
 
LGGNVVVSLEGKPL 1381.8060 1381.8049 0.80 +2 Cofilin-2 f(153-156) 






KVGQAT(phospho)VASGIP 1207.6087 1207.6082 0.41 +2 Phosphoglycerate 
kinase 2 
f(297-308) 
LGRPDGIPMPD 1167.5972 1157.5827 12.53 +2 Phosphoglycerate 
kinase 1 
f(64-74) 





MPVDPPGKPEV 1165.6122 1165.5922 17.16 +2 Titin* f(20115-20125) 
VLDKPGPPAGPL 1160.6854 1160.6674 15.51 +2 Titin* f(28447-28458) 
LAGNPDLVLPV 1107.6598 1107.6408 17.15 +2 β-enolase f(137-147) 
GVQGPVGLPGPAG 1105.5992 1105.6000 -0.72 +2 Collagen α-2(IX) chain f(1003-1015) 
PLS(phospho)LPLLAGL 1073.5942 1073.6006 -5.96 +2 Not assigned / 






PVVPPLIPPK 1056.6934 1056.6816 11.17 +2 Troponin T f(45-54) 
IDGRPGPIGPA 1049.5818 1049.5738 7.62 +2 Collagen α-2(I) chain* f(473-483) 
KEPGPPGTPF 1026.5390 1026.5255 13.15 +2 Titin* f(23348-23357) 
LFDKPVSPL 1015.6020 1015.5823 19.40 +2 Creatine kinase M-type 
Creatine kinase B-type 




NWRPPQPI 1007.5568 1007.5421 14.59 +2 Carbonic anhydrase 3 f(243-250) 
AGNPDLVLPV 994.5556 994.5568 -1.21 +1 β-enolase f(138-147) 
GFNPPDLDI 987.4960 987.4782 18.03 +2 Sarcoplasmic/endoplas
mic reticulum calcium 
ATPase 2 
f(807-815) 













GNPDLVLPV 923.5346 923.5197 16.13 +1 and 
+2 
β-enolase f(139-147) 
FDKPVSPL 902.4961 902.4982 -2.33 +1 and 
+2 
Creatine kinase M-type 
Creatine kinase B-type 




AFPPDVGGN 873.4254 873.4101 17.52 +2 Myosin regulatory light 
chain 2, skeletal muscle 
isoform type 2 
f(142-150) 




SIDDMIPA 861.4072 861.4022 5.80 +1 Creatine kinase M-type 
 
f(372-379) 
KDLFDPI 847.4712 847.4560 17.94 +2 Creatine kinase M-type 
 
f(86-92) 
DIVPGDIV 827.4539 827.4509 3.63 +1 Sarcoplasmic/endoplas
mic reticulum calcium 
ATPase 2 
f(144-151) 












741.4505 -12.54 +1 Derlin 1* f(20-27) 
DKPVSPL 755.4276 755.4298 -2.91 +2 Creatine kinase M-type 
Creatine kinase B-type 












733.4243 -0.55 +1 Titin* f(17144-17151) 








719.3610 -6.12 +1 Creatine kinase M-type f(87-92) 
GITAIEL 716.4046 
 
716.4189 -19.96 +1 Serine/threonine-




701.3716 15.54 +1 α-actinin 3* f(852-857) 
ISVPGPM 700.3699 700.3698 0.14 +1 Collagen α-1(I) chain* f(175-181) 
GVNLPGAA 698.3853 698.3832 3.01 +1 Pyruvate kinase f(208-215) 










FDLGPL 661.3582 661.3556 3.93 +1 Myozenin-1 f(244-249) 











RVDGFG 650.3143 650.3257 -17.53 +1 Not assigned / 
ISGFPK 648.3723 648.3715 1.23 +1 Lactate dehydrogenase 
A-chain 
f(150-155) 
LDRIAG 644.3638 644.3726 -13.66 +1 40S ribosomal protein 
S19 
f(131-136) 





DIKGLP 642.3721 642.3821 -15.57 +1 Titin* f(53-58) 
VEPSLxP 641.3378 641.3505 -19.80 +1 Not assigned / 
IIAPPE 639.3695 
 
639.3712 -2.66 +1 and 
+2 







635.3585 -5.35 +1 and 
+2 
Not assigned / 
KFLxPM 635.3551 
 
635.3585 -5.35 +1 and 
+2 
Not assigned / 







629.3116 13.98 +1 Not assigned / 
HYPLxP 626.3378 626.3297 12.93 +1 Not assigned / 
VGPAPW 626.3378 626.3297 12.93 +1 PDZ and LIM domain 
protein 2* 
f(9-14) 






LxDGVPLx 613.3579 613.3556 3.75 +1 and 
+2 
Not assigned / 
TPIPW 613.3369 613.3344 4.08 +1 Myozenin-1 f(270-274) 
NGIVPI 612.3730 612.3715 2.45 +1 Fructose-bisphosphate 
aldolase A 
f(63-68) 
LDGDLA 603.2935 603.2984 -8.12 +1 Creatine kinase B-type f(105-110) 
VLPGVD 599.3407 599.3399 1.33 +1 Phosphoglycerate 
kinase 1 
f(407-412) 
MPVDK 589.3084 589.3014 11.88 +1 Integrin-linked protein 
kinase* 
f(135-139) 




ENIPI 585.3311 585.3243 11.62 +1 Myozenin-2* f(242-246) 
NQLxPLx 584.3481 584.3402 13.52 +1 Not assigned / 
LLQPI 583.3916 583.3814 17.48 +1 NADH-ubiquinone 
oxidoreductase chain 1 
f(45-49) 
NLGTGL 574.3113 574.3195 -14.28 +1 Creatine kinase M-type 
Creatine kinase B-type 
Creatine kinase U-type 











LELVP 570.3529 570.3497 5.61 +1 Cytochrome c oxidase 
subunit 2 
f(211-215) 
VLxEPLx 570.3529 570.3497 5.61 +1 Not assigned / 
ILNPL 569.3708 569.3657 8.96 +1 NADH-ubiquinone 




569.3770 -18.41 +1 Collagen α-2(V) chain* f(1470-1474) 





LGLLGS 559.3396 559.3450 -9.65 +1 Derlin 3* f(111-116) 
NLxLxPT 557.3318 557.3293 4.49 +1 Not assigned / 
LTIPI 556.3776 556.3705 12.76 +1 NADH-ubiquinone 
oxidoreductase chain 5 
f(15-19) 
NKVPV 556.3381 556.3453 -12.94 +1 Titin* f(30909-30913) 
ARVPL 555.3514 555.3613 -17.83 +1 Myogenin f(46-50) 
RLAPV 555.3514 555.3613 -17.83 +1 Titin* f(9402-9406) 
LxLxVLxP 554.3944 554.3912 5.77 +1 Not assigned / 
LxVLxLxP 554.3944 554.3912 5.77 +1 Not assigned / 
LLLPV 554.3944 554.3912 5.77 +1 Titin* f(27388-27392) 
NIPIP 553.3363 553.3344 3.43 +1 Tropomodulin 1* f(207-211) 
ALGGIL 543.3551 543.3501 9.20 +1 Myoglobin f(72-77) 
LxVTPLx 542.3592 542.3548 8.11 +1 Not assigned / 
ITLPV 542.3592 542.3548 8.11 +1 Phosphoglycerate 
kinase 1 
f(280-284) 




DVLPV 542.3204 542.3184 3.69 +1 β-enolase f(143-147) 
NVVPL 541.3373 541.3344 5.36 +1 NADH-ubiquinone 
oxidoreductase 1 β 
subcomplex subunit 8 
f(20-24) 
 LVLVP  540.3812 540.3756 10.36 +1 Deoxyribonuclease-1-
like 1 
f(153-157) 
ADVDL 532.2657 532.2613 8.27 +1 NADPH-cytochrome 
P450 reductase 
f(159-163) 
LGIDL 530.3136 530.3184 -9.05 +1 Myozenin-1 f(201-205) 
IDILG 530.3136 530.3184 -9.05 +1 Myosin-2 f(339-343) 
ALLVI 528.3758 528.3756 0.38 +1 Myosin-6* f(812-816) 
LSIPV 528.3425 528.3392 6.25 +1 Titin* f(15331-15335) 
LLNAP 527.3284 527.3188 18.21 +1 Dystrophin f(2013-2017) 




VPVPI 524.3474 542.3443 5.72 +1 Titin* f(10751-10755) 





LGLLT 516.3393 516.3392 0.19 +1 Cytochrome c oxidase 
subunit 3 
f(45-49) 
LxALxVV 514.3535 514.3599 -12.44 +1 Not assigned / 
ADLxPV 514.2907 514.2871 7.00 +1 Not assigned / 
VPVVP 510.3299 510.3286 2.55 +1 Pyruvate carboxylase* f(164-168) 
VVPVP 510.3299 510.3286 2.55 +1 Pyruvate kynase* f(527-531) 




LxSPEG 502.2490 502.2508 -3.58 +1 Not assigned / 
LxTAVP 500.3076 500.3079 -0.60 +1 Not assigned / 
VAVPL 498.3305 498.3286 3.81 +1 Derlin-1* f(23-27) 





PFPQ 488.2499 488.2504 -1.02 +1 Fructose-bisphosphate 
aldolase A* 
f(93-96) 











LLEL 487.3183 487.3126 11.70 +1 Troponin T f(75-78) 
RGPVG 485.2876 485.2831 9.27 +2 Collagen α-1(VII) 
chain 
f(1662-1666) 
RVPLx 484.3240 494.3242 -0.41 +1 Various proteins / 
ALxALxP 484.3145 484.3130 3.10 +1 Not assigned / 
APIIA 484.3145 484.3130 3.10 +1 Titin* f(29757-29761) 
FLPT 477.2721 477.2708 2.72 +1 Myozenin-1 f(90-93) 
VFPL 475.2937 475.2915 4.63 +1 Succinate 
dehydrogenase 
f(121-124) 
LGVLA 472.3133 472.3130 0.64 +1 Citrate synthase, 
mitochondrial 
f(430-434) 
LGGIL 472.3124 472.3130 -1.27 +1 Myoglobin f(73-77) 





LxLxLxLx 471.3562 471.3541 4.46 +1 Various proteins / 
LxKPLx 470.3312 470.3337 -5.32 +2 Various proteins / 
VLxLLx 457.3441 457.3384 12.46 +1 Sarcoplasmic/endoplas




LGGLP 456.2808 456.2817 -1.97 +1 Myomesin-1* f(1575-1579) 
LLGPG 456.2808 456.2817 -1.97 +1 Serine/threonine-
protein phosphatase 1 
regulatory subunit 10 
f(619-623) 
LxLxLxP 455.3246 455.3228 3.95 +1 Various proteins / 





LVLT 445.2993 445.3021 -6.29 +1 NADH-ubiquinone 
oxidoreductase chain 4 
f(66-69) 
VLxLxV 443.3152 443.3228 -16.92 +1 Various proteins / 
LxVLxV 443.3152 443.3228 -16.92 +1 Various proteins / 
LxVVLx 443.3152 443.3228 -16.92 +1 Various proteins / 
VLxVLx 443.3152 443.3228 -16.92 +1 Various proteins / 
LxVLxP 441.3081 441.3071 2.27 +1 Various proteins / 




LxLxPV 441.3081 441.3071 2.27 +1 Various proteins / 
VLxLxP 441.3081 441.3071 2.27 +1 Various proteins / 





TLVP 429.2701 429.2708 -1.63 +1 NADH-ubiquinone 
oxidoreductase chain 4 
f(125-128) 
VLPV 427.2917 427.2915 0.47 +1 β-enolase f(144-147) 
WLxT 419.2296 419.2289 1.67 +1 Various proteins / 
VALxLx 415.2846 415.2915 -16.61 +1 Various proteins / 
LxAPLx 413.2756 413.2758 -0.48 +1 Various proteins / 
LxALxP 413.2756 413.2758 -0.48 +1 Various proteins / 
VALxT 403.2622 403.2551 17.61 +1 Various proteins / 
AVVLx 401.2749 401.2758 -2.24 +1 Various proteins / 
VALxV 401.2749 401.2758 -2.24 +1 Various proteins / 
LxGLxP 399.2602 399.2602 0.00 +1 Various proteins / 
AVLxP 399.2602 399.2602 0.00 +1 Various proteins / 
LxLxF 392.2570 392.2544 6.63 +1 Various proteins / 
YPLx 392.2193 392.2180 3.31 +1 Various proteins / 
VGPLx 385.2448 385.2445 0.78 +1 Various proteins / 
FLxV 378.2403 378.2387 4.23 +1 Various proteins / 
LxLxM 376.2238 376.2265 -7.18 +1 Various proteins / 
LxFP 376.2238 376.2231 1.86 +1 Various proteins / 
PFLx 376.2238 376.2231 1.86 +1 Various proteins / 
LxPF 376.2238 376.2231 1.86 +1 Various proteins / 
FPLx 376.2238 376.2231 1.86 +1 Various proteins / 
FLxP 376.2238 376.2231 1.86 +1 Various proteins / 
GIW 375.2034 375.2027 1.87 +1 Creatine kinase M-type 
Creatine kinase B-type 








LxGLxA 373.2438 373.2445 -1.88 +1 Various proteins / 
VPR 371.2403 371.2401 0.54 +1 Various proteins / 
FPV 362.2065 362.2074 -2.48 +1 Various proteins / 
VPF 362.2065 362.2074 -2.48 +1 Various proteins / 
LxPM 360.1899 360.1952 -14.71 +1 Various proteins / 
GLxLxG 359.2288 359.2289 -0.28 +1 Various proteins / 
LxLxLx 358.2700 358.2700 0.00 +1 Various proteins / 
KPLx 357.2459 357.2496 -10.36 +1 Various proteins / 
LxTLx 346.2337 346.2336 0.29 +1 Various proteins / 
TLxLx 346.2337 346.2336 0.29 +1 Various proteins / 
VLxLx 344.2523 344.2544 -6.10 +1 Various proteins / 
LxLxV 344.2523 344.2544 -6.10 +1 Various proteins / 
LxPLx 342.2370 342.2387 -4.97 +1 Various proteins / 
LxLxP 342.2370 342.2387 -4.97 +1 Various proteins / 





FLxG 336.1905 336.1918 -3.87 +1 Various proteins / 
WM 336.1374 336.1376 -0.59 +1 Various proteins / 
SLxLx 332.2124 332.2180 -16.86 +1 Various proteins / 
LxLxS 332.2124 332.2180 -16.86 +1 Various proteins / 
LxVV 330.2354 330.2387 -9.99 +1 Various proteins / 
VLxV 330.2354 330.2387 -9.99 +1 Various proteins / 
LxPV 328.2234 328.2231 0.91 +1 Various proteins / 
LxVP 328.2234 328.2231 0.91 +1 Various proteins / 
VLxP 328.2234 328.2231 0.91 +1 Various proteins / 
LxW 318.1804 318.1812 2.51 +1 Various proteins / 




FF 313.1540 313.1547 -2.24 +1 Various proteins / 
VW 304.1568 304.1656 0.66 +1 Various proteins / 
LxGLx 302.2082 302.2074 2.65 +1 Various proteins / 
FM 297.1304 297.1267 12.45 +1 Various proteins / 
LxR 288.2048 288.2030 6.25 +1 Various proteins / 
FLx 279.1658 279.1703 16.12 +1 Various proteins / 
LxF 279.1658 279.1703 16.12 +1 Various proteins / 
VF 265.1523 265.1547 -9.05 +1 Various proteins / 
FV 265.1523 265.1547 -9.05 +1 Various proteins / 
LxM 263.1383 263.1424 -15.58 +1 Various proteins / 
MLx 263.1383 263.1424 -15.58 +1 Various proteins / 
PF 263.1375 263.1390 -5.70 +1 Various proteins / 
LxK 260.1973 260.1969 1.54 +1 Various proteins / 
DLx 247.1284 247.1288 -1.62 +1 Various proteins / 
LxLx 245.1818 245.1860 -17.13 +1 Various proteins / 
LxV 231.1748 231.1703 19.47 +1 Various proteins / 
VLx 231.1748 231.1703 19.47 +1 Various proteins / 
PLx 229.1504 229.1547 -18.76 +1 Various proteins / 
LxP 229.1504 229.1547 -18.76 +1 Various proteins / 
AH 227.1125 227.1139 -6.16 +1 Various proteins / 
ALx 203.1357 203.1390 -16.25 +1 Various proteins / 
AV 189.1268 189.1234 17.98 +1 Various proteins / 
GLx 189.1268 189.1234 17.98 +1 Various proteins / 
aMass are reported as monoisotopic.  
bPeptides were matched versus Sus scrofa proteins by using Peptide Match 
(https://research.bioinformatics.udel.edu/peptidematch/index.jsp#) 
*means that the peptide was identified in the corresponding human protein  





Table S3. Peptides identified in the <3 kDa permeate obtained from beef after 








Charge Proteinb Fragment 
GELGPVGNPGPSGPAGPR 1615.8314 1615.8187 7.86 +2 Collagen α-2(I) chain f(263-281) 
IDGRPGPIGPAGARGEA 
 
1590.8404 1590.8347 3.58 +3 Collagen α-2(I) chain f(471-487) 
GLTGPIGPPGPSGAPGDK 1574.8326 1574.8173 9.72 +2 Collagen α-1(I) chain f(763-780) 
 








MDPIAPPGKPQNPR 1517.8108 1517.7893 14.16 +3 Titin* f(32595-32608) 




ALDPIDPPGKPVPL 1428.8192 1428.8097 6.65 +2 Titin* f(23921-23934) 
PSRPVVPPLIPPK 1396.8889 1396.8675 15.32 +3 Troponin T f(43-55) 




VLDRPGPPEGPL 1246.6908 1246.6790 9.47 +2 Titin* f(24119-24130) 
f(27366-27377) 
VLDRPGPPEGPV 1232.6762 1232.6634 10.38 +2 Titin* f(25201-25212) 
f(26283-26294) 
RPVVPPLIPPK 1212.8061 1212.7827 19.29 +3 Troponin T f(45-55) 
IDIS(phospho)QLVITK 1209.6322 1209.6490 -13.89 +2 DNA polymerase delta 
catalytic subunit  
f(875-884) 
 
KVGQAT(phospho)VASGIP 1207.6058 1207.6082 -1.99 +2 Phosphoglycerate 
kinase 2 
f(297-308) 
KDLFDPIIQD 1203.6424 1203.6256 13.96 +2 Creatine kinase M-type f(86-95) 
AVFPSIVGRPR 1198.7200 1198.7055 12.10 +3 Actin, cytoplasmic 1 










VLDKPGPPAGPL 1160.6834 1160.6674 13.79 +2 Titin* f(28447-28458) 
FPGIGVLPGVPT 1153.6620 1153.6616 0.35 +1 Elastin f(171-182) 
LGRPDGVPMPD 1153.5826 1153.5670 13.52 +2 Phosphoglycerate 
kinase 1 
f(64-74) 




GFNPPDLDIM 1118.5140 1118.5187 -4.20 +1 Sarcoplasmic/endoplas
mic reticulum calcium 
ATPase 2 
f(807-816) 
GVQGPVGLPGPAG 1105.5872 1105.6000 -11.58 +2 Collagen α-1(IX) chain  
Collagen α-2(IX) chain 
f(872-884) 
f(1063-1075) 
PVVPPLIPPK 1056.6942 1056.6816 11.92 +1 Troponin T f(46-55) 
IDGRPGPIGPA 1049.5706 1049.5738 -3.05 +2 Collagen α-2(I) chain* f(471-481) 
ALESPERPF 1045.5468 1045.5313 14.82 +2 Phosphoglycerate 
kinase 1 
f(200-208) 
AGNPELILPV 1022.5880 1022.5881 -0.10 +1 β-enolase f(138-147) 




LFDKPVSPL 1015.6012 1015.5823 18.61 +2 Creatine kinase M-type 
Creatine kinase B-type 
Creatine kinase U-type 





NWRPPQPI 1007.5560 1007.5421 13.80 +2 Carbonic anhydrase 3 f(243-250) 
GFNPPDLDI 987.4928 987.4782 14.79 +2 Sarcoplasmic/endoplas
mic reticulum calcium 
ATPase 1 
f(807-815) 
LTEAPLNPK 982.5642 982.5568 7.53 +2 Actin, cytoplasmic 1 






DLFDPIIQ 960.5060 960.5037 2.39 +1 Creatine kinase M-type f(87-94) 
GNPELILPV 951.5658 951.5510 15.55 +2 β-enolase f(139-147) 





VVLPGPAPW 935.5520 935.5349 18.28 +2 PDZ and LIM domain 
protein 3 
f(5-13) 
FDKPVSPL 902.5128 902.4982 16.18 +1 and 
+2 
Creatine kinase M-type 
Creatine kinase B-type 
Creatine kinase U-type 









LVPPSVEL 853.5192 853.5029 19.10 +2 Titin* f(20073-20080) 
KDLFDPI 847.4660 847.4560 11.80 +2 Creatine kinase M-type 
 
f(86-92) 
IETLLPR 841.5258 841.5142 13.78 +2 Glycogen 
phosphorylase 
f(393-399) 
GPSWDPF 805.3546 805.3515 3.85 +1 Heat shock protein β-1 f(13-19) 
IIAPPER 795.4772 
 
795.4723 6.16 +2 Actin, cytoplasmic 1 









AVFPSIVG 789.4514 789.4505 1.14 +2 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 
Actin, cytoplasmic 5 





LRPPLPS 779.4711 779.4774 -8.08 +1 Splicing factor 3A 
subunit 1 
f(458-464) 
VIGGLPDV 769.4487 769.4454 4.29 +1 M-protein, striated 
muscle 
f(1334-1341) 
DLKGIPL 755.4560 755.4662 -13.15 +1 Titin* f(53-59) 
AATVAVPL 741.4396 
 
741.4505 -14.70 +1 Derlin 1 f(20-27) 
VIPELNG 741.4163 
 




PMVGIPL 726.4307 726.4219 12.11 +1 UDP-glucurunosyl-
transferase 3A1 
f(384-390) 
APGIIPR 723.4564 723.4512 7.19 +2 ATP synthase subunit 
α, mitochondrial 
f(176-182) 
ISVPGPM 700.3699 700.3698 0.14 +1 Collagen α-1(I) chain f(174-180) 
GVNLPGAA 698.3868 698.3832 5.15 +1 Pyruvate kinase f(242-249) 




FDLGPL 661.3580 661.3556 3.63 +1 Myozenin-1 f(243-248) 




LANLIL 656.4343 656.4341 0.30 +1 Spastin f(322-327) 





651.3171 1.69 +1 Actin, cytoplasmic 1 










DVSIPL 643.3578 643.3661 -12.90 +1 Exostosin-1 f(213-236) 
DIKGLP 642.3718 642.3821 -16.03 +1 Titin* f(53-58) 
VQALPL 640.4042 640.4028 2.19 +1 Sentrin-specific 
protease 7 
f(657-662) 













LKYPI 633.4010 633.3970 6.32 +2 Actin, cytoplasmic 1  






IGGSILA 630.3815 630.3821 -0.95 +1 Actin, cytoplasmic 1 








629.3116 13.98 +1 Not assigned / 
RLAPAV 626.3881 626.3984 -16.44 +1 Protein TBRG4 f(18-23) 
HYPLP 626.3346 626.3297 7.82 +1 Endoplasmic reticulum 
aminopeptidase 2 
f(311-315) 
VGPAPW 626.3346 626.3297 7.82 +1 PDZ and LIM domain 
protein 2 
f(8-13) 
EVAPLP 625.3657 625.3556 16.15 +1 Tripartite motif-
containing protein 54 
f(159-164) 






LDGVPI 613.3579 613.3556 3.75 +1 ADP-ribosylation 
factor-related protein 1 
f(124-129) 
TPIPW 613.3369 613.3344 4.08 +1 Myozenin-1 f(269-273) 
NGIVPI 612.3731 612.3715 2.61 +1 Fructose-bisphosphate 
aldolase A 
f(181-186) 
LxLxLxPR 611.4278 611.4239 6.38 +2 Various proteins / 




NDIKN 603.3111 603.3097 2.32 +1 cAMP-dependent 
protein kinase catalytic 
subunit α 
f(290-294) 
LDGDLA 603.3059 603.2984 12.43 +1 Creatine kinase B-type f(165-170) 
MPVDK 589.3073 589.3014 10.01 +1 Integrin-linked protein 
kinase* 
f(135-139) 
LVLPF 588.3762 588.3756 1.02 +1 Collagen α-1(XI) chain f(260-264) 
LxFVPI 588.3762 588.3756 1.02 +1 Titin* f(22807-22811) 
f(23889-23893) 
ENIPI 585.3341 585.3243 16.74 +1 Myozenin-2 f(242-246) 
NQLxPLx 584.3469 584.3402 11.47 +1 Not assigned / 












VLxEPLx 570.3518 570.3497 3.68 +1 Not assigned / 
ILNPL 569.3712 569.3657 9.66 +1 NADH-ubiquinone 




569.3770 -19.64 +1 Collagen α-2(V) chain* f(1470-1474) 
LSFPT 564.3042 564.3028 2.48 +1 Hemoglobin subunit α f(35-39) 
IGGSIL 559.3459 559.3450 1.61 
 
+1 Actin, cytoplasmic 1 






LGLLGS 559.3408 559.3450 -7.51 +1 Derlin 3* f(111-116) 
NLxLxPT 557.3307 557.3293 2.51 +1 Not assigned / 
LTIPI 556.3683 556.3705 -3.95 +1 Titin* f(31083-31087) 
IITPL 556.3683 556.3705 -3.95 +1 Titin* f(3347-3351) 
ARVPL 555.3560 555.3613 -2.34 +1 Myogenin f(46-50) 
RLAPV 555.3600 555.3613 -2.34 +1 Titin* f(9402-9406) 
LxLxVLxP 554.3933 554.3912 3.79 +1 Not assigned / 
LxVLxLxP 554.3933 554.3912 3.79 +1 Not assigned / 
LLLPV 554.3933 554.3912 3.79 +1 Titin* f(27388-27392) 
NIPIP 553.3378 553.3344 6.14 +1 Tropomodulin 1 f(207-211) 
IIGGGM 547.2856 547.2908 -9.50 +1 Phosphoglycerate 
kinase 1 
f(235-240) 
LxANLxLx 543.3519 543.3501 3.31 +1 Various proteins / 
ALGGIL 543.3503 543.3501 0.37 +1 Myoglobin f(72-77) 
LVTPL 542.3578 542.3548 5.53 +1 ATP dependent RNA 
helicase A 
f(1058-1062) 
ITLPV 542.3578 542.3548 5.53 +1 Phosphoglycerate 
kinase 1 
f(280-284) 
DVLPV 542.3178 542.3184 -1.11 +1 β-enolase f(143-147) 
AEILP 542.3178 542.3184 -1.11 +1 NADH-ubiquinone 
oxidoreductase iron-
sulfur protein 3 
f(68-72) 






LVLVP 540.3770 540.3756 2.59 +1 Deoxyribonuclease-1-
like 1 
f(152-156) 
PFGNT 535.2503 535.2511 -1.49 +1 Creatine kinase M-type 






Creatine kinase U-type 
Creatine kinase S-type 
f(2-6) 
f(2-6) 
LGIDL 530.3131 530.3184 -9.99 +1 Myozenin-1 f(200-204) 
ALLVI 528.3726 528.3756 -5.68 +1 Myosin-6* f(812-816) 
LSIPV 528.3425 528.3392 6.25 +1 Titin* f(15331-15335) 
LLNAP 527.3284 527.3188 18.21 +1 Dystrophin* f(2017-2021) 




VPLxTP 526.3214 526.3235 -3.99 +1 Not assigned / 
VPVPI 524.3471 542.3443 5.16 +1 Titin* f(10751-10755) 
AVFPS 520.2771 520.2766 0.96 +1 Actin, cytoplasmic 1 










LxALxVV 514.3515 514.3599 -16.33 +1 Not assigned / 
ADLxPV 514.2871 514.2871 0.00 +1 Not assigned / 
VPVVP 510.3285 510.3286 -0.20 +1 Pyruvate carboxylase* f(164-168) 
VVPVP 510.3285 510.3286 -0.20 +1 Pyruvate kynase f(561-565) 




LxSPEG 502.2515 502.2508 1.39 +1 Not assigned / 
LxTAVP 500.3006 500.3079 -14.59 +1 Not assigned / 
VAVPL 498.3297 498.3286 2.21 +1 Derlin-1* f(23-27) 
LxLxLxM 489.3094 489.3105 -2.25 +1 Various proteins / 
PTLxPA 498.3007 498.2922 17.37 +1 Not assigned / 
GLxLxW 488.2876 488.2867 1.84 +1 Various proteins / 
PFPQ 488.2423 488.2504 -16.59 +1 Fructose-bisphosphate 
aldolase A* 
f(93-96) 
RGPVG 485.2922 485.2831 18.75 +2 Collagen α-1(III) chain  
Collagen α-1(IV) chain  







RVPL 484.3140 494.3242 -0.41 +1 Myogenin f(47-50) 
LxTLxM 477.2720 477.2741 -4.40 +1 Various proteins / 
LxTFP 477.2720 477.2708 2.51 +1 Various proteins / 
FLPT 477.2720 477.2708 2.51 +1 Myozenin-1 f(90-93) 
VFPL 475.2938 475.2915 4.84 +1 Fatty acid synthase f(1697-1700) 




LGVLA 472.3110 472.3130 -4.23 +1 Citrate synthase, 
mitochondrial 
f(430-434) 
LxGAVLx 472.3110 472.3130 -4.23 +1 Various proteins / 
LGGIL 472.3110 472.3130 -4.23 +1 Myoglobin f(73-77) 
PSIVG 472.2801 472.2766 7.41 +1 Actin, cytoplasmic 1 






LxLxLxLx 471.3563 471.3541 4.67 +1 Various proteins / 
LxKPLx 470.3394 470.3337 12.12 +2 Various proteins / 
PLxLxGA 470.2951 470.2973 -4.68 +1 Not assigned / 
LxGLxTG 460.2724 460.2766 -9.12 +1 Not assigned / 
VLxLxLx 457.3395 457.3384 2.41 +1 Various proteins / 
LLGPG 456.2751 456.2817 -14.46 +1 ATP synthase F(0) 
complex subunit B1 
f(22-26) 
LxLxLxP 455.3246 455.3228 3.95 +1 Various proteins / 
VFPS 449.2347 499.2395 -10.68 +1 Actin, cytoplasmic 1 






LxAMLx 447.2593 447.2636 -9.61 +1 Various proteins / 
LxVLxT 445.3011 445.3021 -2.25 +1 Various proteins / 
LxTLxV 445.3011 445.3021 -2.25 +1 Various proteins / 
VLxLxV 443.3221 443.3228 -1.58 +1 Various proteins / 
LxVLxV 443.3221 443.3228 -1.58 +1 Various proteins / 




VLxVLx 443.3221 443.3228 -1.58 +1 Various proteins / 
LxVLxP 441.3082 441.3071 2.49 +1 Various proteins / 
LxLxVP 441.3082 441.3071 2.49 +1 Various proteins / 
LxLxPV 441.3082 441.3071 2.49 +1 Various proteins / 
VLxLxP 441.3082 441.3071 2.49 +1 Various proteins / 
FLxR 435.2697 435.2714 -3.91 +1 Various proteins / 
VLxLxS 431.2820 431.2864 -10.20 +1 Various proteins / 
LxLxW 431.2703 431.2653 11.59 +1 Various proteins / 
VLPV 427.2914 427.2915 -0.23 +1 β-enolase f(144-147) 
WLxT 419.2286 419.2289 -0.72 +1 Various proteins / 
LxWV 417.2501 417.2496 1.20 +1 Various proteins / 
VLxLxA 415.2919 415.2915 0.96 +1 Various proteins / 
VALxLx 415.2919 415.2915 0.96 +1 Various proteins / 
LxALxV 415.2919 415.2915 0.96 +1 Various proteins / 
LxAPLx 413.2724 413.2758 -8.22 +1 Various proteins / 
FPF 410.2107 410.2074 8.04 +1 Various proteins / 
FSVG 409.2003 409.2082 -19.31 +1 Various proteins / 
VALxT 403.2543 403.2551 -1.98 +1 Various proteins / 
VALxV 401.2744 401.2758 -3.49 +1 Various proteins / 
LxGLxP 399.2573 399.2602 -7.26 +1 Various proteins / 
FLxLx 392.2579 392.2544 8.92 +1 Various proteins / 
LxLxF 392.2579 392.2544 8.92 +1 Various proteins / 
FLxV 378.2403 378.2387 4.23 +1 Various proteins / 
LxLxM 376.2234 376.2265 -8.24 +1 Various proteins / 
LxFP 376.2234 376.2231 0.80 +1 Various proteins / 




LxPF 376.2234 376.2231 0.80 +1 Various proteins / 
FPLx 376.2234 376.2231 0.80 +1 Various proteins / 
FLxP 376.2234 376.2231 0.80 +1 Various proteins / 
GIW 375.2026 375.2027 -0.27 +1 Creatine kinase M-type 
Creatine kinase B-type 




LxGLxA 373.2504 373.2445 15.81 +1 Various proteins / 
VPR 371.2451 371.2401 13.47 +1 Various proteins / 
GLxLxG 359.2310 359.2289 5.85 +1 Various proteins / 
LxLxLx 358.2700 358.2700 0.00 +1 Various proteins / 
KPLx 357.2458 357.2496 -10.64 +1 Various proteins / 
VLxLx 344.2515 344.2544 -8.42 +1 Various proteins / 
LxLxV 344.2515 344.2544 -8.42 +1 Various proteins / 
LxPLx 342.2354 342.2387 -9.64 +1 Various proteins / 
LxLxP 342.2354 342.2387 -9.64 +1 Various proteins / 
AVF 336.1905 336.1918 -3.87 +1 Actin, cytoplasmic 1 






FLxG 336.1877 336.1918 -12.20 +1 Various proteins / 
LxPV 328.2224 328.2231 -2.13 +1 Various proteins / 
LxW 318.1771 318.1812 -12.89 +1 Various proteins / 
WLx 318.1771 318.1812 -12.89 +1 Various proteins / 
LxGLx 302.2086 302.2074 3.97 +1 Various proteins / 
LxR 288.2059 288.2030 10.06 +1 Various proteins / 
FLx 279.1709 279.1703 2.15 +1 Various proteins / 
LxF 279.1709 279.1703 2.15 +1 Various proteins / 
AGQ 275.1370 275.1350 7.27 +1 Various proteins / 
LxH 269.1615 269.1608 2.60 +1 Various proteins / 




LxK 260.1920 260.1969 -18.83 +1 Various proteins / 
LxLx 245.1819 245.1860 -16.72 +1 Various proteins / 
PLx 229.1529 229.1547 -7.85 +1 Various proteins / 
LxP 229.1529 229.1547 -7.85 +1 Various proteins / 
AH 227.1110 227.1139 -12.77 +1 Various proteins / 
PV 215.1355 215.1390 -16.27 +1 Various proteins / 
ALx 203.1351 203.1390 -19.20 +1 Various proteins / 
aMass are reported as monoisotopic.  
bPeptides were matched versus Bos taurus proteins by using Peptide Match 
(https://research.bioinformatics.udel.edu/peptidematch/index.jsp#) 
*means that the peptide was identified in the corresponding human protein  





Table S4. Peptides identified in the <3 kDa permeate obtained from chicken meat after 








Charge Proteinb Fragment 
ALDPIDPPGKPVPL 1428.8228 1428.8097 9.17 +2 Titin* f(23921-23934) 
SWEAPPFDGGMPI 1403.6442 1403.6300 10.12 +2 Myosin-binding protein 
C 
f(650-662) 
TWEPPIIDGGSPI 1381.7156 1381.6698 11.44 +2 Titin* f(22374-22380) 
PEILPDGDHDLK 1348.6996 1348.6743 18.76 +3 Fructose-bisphosphate 
aldolase C 
f(189-200) 
TWEPPLLDGGSK 1299.6722 1299.6579 11.00 +2 Titin* f(25621-25632) 
SWEPPLIDGGAK 1269.6656 1269.6474 14.33 +2 Titin* f(27786-27797) 
VLDRPGPPEGPL 1246.6952 1246.6790 12.99 +2 Titin* f(24119-24130) 
f(27366-27377) 
LDVPISGEPAPT 1195.6342 1195.6205 11.46 +2 Myosin-binding protein 
C 
f(556-567) 




LVIIEGDLER 1156.6688 1156.6572 10.03 +2 Tropomyosin α-1 chain f(169-178) 
VVDVPDPPQSV 1151.6098 1151.5943 13.46 +2 Myosin-binding protein 
C 
f(626-637) 
GDLGIEIPAEK 1141.6028 1141.6099 -6.22 +2 Pyruvate kinase f(294-304) 




ALESPERPF 1045.5496 1045.5313 17.50 +2 Phosphoglycerate 
kinase 1 
f(200-208) 
IQIPGPPTNV 1035.5970 1035.5833 13.23 +2 M-protein, striated 
muscle 
f(496-505) 




LFDKPVSPL 1015.5974 1015.5823 14.87 +2 Creatine kinase M-type 
Creatine kinase B-type 




LTEAPLNPK 982.5700 982.5568 13.43 +2 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 







VDLPAVSEK 957.5388 957.5251 14.31 +2 Pyruvate kinase f(215-223) 
SWDPPVPR 953.5002 953.4839 17.10 +2 M-protein, striated 
muscle 
f(518-525) 








DLFDPVIQ 946.4912 946.4880 3.38 +1 Creatine kinase M-type f(87-94) 
LxLxPLxEPELx 923.5618 923.5448 18.41 +2 Not assigned / 
MYPGIADR 922.4580 922.4451 13.98 +2 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 















KDLFDPV 833.4496 833.4403 11.16 +2 Creatine kinase M-type f(86-92) 









795.4723 6.41 +2 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 







AVFPSIVG 789.4505 789.4505 0.00 +2 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 












766.3440 2.61 +1 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 







EEFLPM 765.3554 765.3488 8.62 +2 Myosin, light chain 1 
Myosin, light chain 3 
f(109-114) 
f(67-72) 




GFNPPDL 759.3700 759.3672 3.69 +1 Sarcoplasmic/endoplas
mic reticulum calcium 
ATPase 2 
f(808-814) 




DKPVSPL 755.4442 755.4298 19.06 +2 Creatine kinase M-type 
Creatine kinase B-type 












741.4505 -18.48 +1 Derlin 1* f(20-27) 
VIPELNG 741.4180 
 






733.4243 -0.82 +1 Titin* f(17144-17151) 
AVFPSIV 732.4301 732.4291 1.37 +1 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 









730.3770 4.66 +1 Titin* f(17762-17768) 
LILPVPA 722.4805 722.4811 -0.83 +1 β-enolase f(143-149) 
GLxTALxELx 716.4050 716.4189 -19.40 +1 Not assigned / 
DLFDPV 705.3493 705.3454 5.53 +1 Creatine kinase M-type f(87-92) 
GVNLPGAA 698.3854 698.3832 3.15 +1 Pyruvate kinase f(207-214) 
DFGMDL 697.2901 697.2862 5.59 +1 Myosin, heavy chain f(515-520) 
MLTLPI 687.4192 687.4111 11.78 +1 NADH-ubiquinone 
oxidoreductase chain 5 
f(129-134) 
MDLxVPLx 687.3794 687.3746 6.98 +1 Not assigned / 














ENLxPPLx 682.3870 682.3770 14.64 +1 Not assigned / 




 VITEPI  671.3997 671.3974 3.43 +1 Not assigned / 
VLPGVDA 670.3783 670.3770 1.94 +1 Phosphoglycerate 
kinase 1 
f(407-413) 
LxLxLxLxVP 667.4757 667.4753 0.60 +1 Not assigned / 
NVDTLxP 658.3473 658.3406 10.18 +1 Not assigned / 
LxTLxTPLx 657.4136 657.4182 -7.00 +1 Not assigned / 




PSLxLxLxLx 655.4341 655.4389 -7.32 +1 Not assigned / 





651.3171 4.45 +1 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 







RVDGFG 650.3160 650.3257 -14.92 +1 Not assigned / 
LGIHPL 649.4110 649.4032 12.01 +2 Lactate dehydrogenase 
A-chain 
f(178-183) 




LxDRLxAG 644.3620 644.3726 -16.45 +1 Not assigned / 
LTEAPL 643.3686 643.3661 3.89 +1 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 







VQALxPLx 640.4052 640.4028 3.75 +1 Not assigned / 
IIAPPE 639.3725 
 
639.3712 2.03 +1 and 
+2 
Actin, cytoplasmic 1 
Actin, cytoplasmic 2 







EFLPM 636.3097 636.3062 5.50 +1 Myosin, light chain 1 
Myosin, light chain 3 
f(110-114) 
f(68-72) 
YGNPW 636.2811 636.2776 5.50 +1 Glycogen 
phosphorylase* 
f(186-190) 
LSFHQ 631.3229 631.3198 4.91 +1 Kinesin-like protein 
KIF18B 
f(189-193) 
MPIAPT 629.3351 629.3327 3.81 +1 Myosin-binding protein 
C 
f(724-729) 
HYPLP 626.3346 626.3297 7.82 +1 Not assigned / 
VGPAPW 626.3346 626.3297 7.82 +1 PDZ and LIM domain 
protein 2* 
f(8-13) 
LALLVP 625.4287 625.4283 0.64 +1 Solute carrier family 46 
member 3 
f(448-453) 
DIAPPI 625.3627 625.3556 11.35 +1 Ubiquitin carboxyl-
terminal hydrolase 13 
f(623-628) 
LxKLxPF 617.4122 617.4021 16.36 +2 Titin* f(25241-25245) 
f(31974-31978) 
LxEKDLx 617.3532 617.3505 4.37 +2 Not assigned / 
LTRLL 615.4074 615.4188 -18.52 +1 Kinesin-like protein 
KIF18B 
f(309-313) 






LxDGVPLx 613.3584 613.3556 4.57 +1 and 
+2 
Not assigned / 
TPIPW 613.3373 613.3344 4.73 +1 Myozenin-1* f(271-275) 
NGLVPI 612.3725 612.3715 1.63 +1 Fructose-bisphosphate 
aldolase B 
f(181-186) 
LxLxVPPA 609.3979 609.3970 1.48 +1 Not assigned / 
FTQPL 605.3307 605.3293 2.31 +1 Actin-related protein 3 f(292-296) 
NDIKN 603.3122 603.3097 4.14 +1 cAMP-dependent 
protein kinase catalytic 
subunit α 
f(290-294) 
LDGDLA 603.3008 603.2984 3.98 +1 Creatine kinase B-
type* 
f(165-170) 
MPLxNK 602.3450 602.3330 19.92 +1 Not assigned / 
LxLxGNLxA 600.3747 600.3715 5.33 +1 Not assigned / 
VLPGVD 599.3424 599.3399 4.17 +1 Phosphoglycerate 
kinase 1 
f(407-412) 
LVIPF 588.3768 588.3756 2.04 +1 Myosin-binding protein 
C 
f(852-856) 
LxFVPI 588.3768 588.3756 2.04 +1 Titin* f(22807-22811) 
f(23889-23893) 




ENIPI 585.3345 585.3243 17.43 +1 Myozenin-2* f(242-246) 
APIIAV 583.3838 583.3814 4.11 +1 Pyruvate kinase f(447-452) 






ITEPI 572.3336 572.3290 8.04 +1 M-protein, striated 
muscle 
f(587-591) 
QVVLxLx 571.3701 571.3814 -19.78 +1 Not assigned / 
LxELxVP 570.3526 570.3497 5.08 +1 Not assigned / 
VLxEPLx 570.3526 570.3497 5.08 +1 Not assigned / 
TVFPV 562.3275 562.3235 7.11 +1 Not assigned / 
IGGSIL 559.3459 559.3450 1.61 +1 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 











NLxLxPT 557.3309 557.3293 2.87 +1 Not assigned / 
LTIPI 556.3679 556.3705 -4.67 +1 Titin* f(31083-31087) 
IITPL 556.3679 556.3705 -4.67 +1 Titin* f(3347-3351) 
NKVPV 556.3387 556.3453 -11.86 +1 Titin* f(30909-30913) 
MPVPL 556.3187 556.3163 4.31 +1 Not assigned / 
ARVPL 555.3506 555.3613 -19.27 +1 Not assigned / 
RLAPV 555.3506 555.3613 -19.27 +1 Titin* f(9402-9406) 
LxLxVLxP 554.3932 554.3912 3.61 +1 Not assigned / 
LLLPV 554.3932 554.3912 3.61 +1 Titin* f(27388-27392) 
NIPIP 553.3363 553.3344 3.43 +1 Tropomodulin 1* f(207-211) 
LxANLxLx 543.3519 543.3501 3.31 +1 Various proteins / 
ITLPV 542.3561 542.3548 2.40 +1 Phosphoglycerate 
kinase 1 
f(280-284) 
TPVLxLx 542.3561 542.3548 2.40 +1 Not assigned / 
DVLPV 542.3216 542.3184 5.90 +1 β-enolase* f(143-147) 
PSEPI 542.2916 542.2821 17.52 +1 Collagen α-1(XII) 
chain 
f(411-415) 
FIDF 541.2687 541.2657 5.54 +1 Myosin heavy chain f(513-516) 
LxVLxVP 540.3770 540.3756 2.59 +1 Not assigned / 
IDILG 530.3128 530.3184 -10.56 +1 Myosin heavy chain f(339-343) 
ALLVI 528.3699 528.3756 -10.79 +1 Myosin-6* f(812-816) 
LSIPV 528.3414 528.3392 4.16 +1 Titin* f(15331-15335) 




AIIPL 526.3611 526.3599 2.28 +1 NADH-ubiquinone 
oxidoreductase chain 2 
f(39-43) 
AVFPS 520.2778 520.2766 2.31 +1 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 







RFPV 518.2985 518.3085 -19.29 +1 Serine/threonine-
protein kinase STK11 
f(147-150) 










LxALxVV 514.3539 514.3599 -11.66 +1 Not assigned / 
ADLxPV 514.2913 514.2871 8.17 +1 Not assigned / 
VPVVP 510.3303 510.3286 3.33 +1 Pyruvate carboxylase* f(164-168) 
VVPVP 510.3303 510.3286 3.33 +1 Pyruvate kinase f(526-530) 
FQPLx 504.2830 504.2817 2.58 +1 Titin* f(3823-3826) 
f(7504-7507) 
LxAGGW 503.2622 503.2613 1.79 +1 Not assigned / 
LLGSI 502.3265 502.3235 5.97 +1 Myosin heavy chain f(748-752) 
LxTAVP 500.3025 500.3079 -10.79 +1 Not assigned / 
VAVPL 498.3300 498.3286 2.81 +1 Derlin-1* f(23-27) 
FVEV 493.2673 493.2657 3.24 +1 Phosphoglycerate 
kinase 1 
f(324-327) 




INPF 490.2669 490.2660 1.84 +1 Titin* f(32371-32374) 
LxLxFP 489.3089 489.3071 3.68 +1 Various proteins / 
LFPI 489.3089 489.3071 3.68 +1 NADH-ubiquinone 
oxidoreductase chain 1 
f(261-264) 
PFPQ 488.2416 488.2504 -18.02 +1 Fructose-bisphosphate 
aldolase A* 
f(93-96) 
WPW 488.2325 488.2292 2.66 +1 Myosin heavy chain f(830-832) 
LIEL 487.3170 487.3126 9.03 +1 Troponin T f(75-78) 
TVAPV 486.2938 486.2922 3.29 +1 Not assigned / 
RGPVG 485.2922 485.2831 18.75 +2 Collagen α-1(IX) chain  
Collagen α-2(IX) chain  
f(505-509) 
f(391-395) 
RVPL 484.3151 494.3242 -18.79 +1 Sarcoplasmic/endoplas
mic reticulum calcium 
ATPase 1 
f(534-537) 
APIIA 484.3151 484.3130 4.34 +1 Titin* f(29757-29761) 
LxTFP 477.2714 477.2708 1.26 +1 Not assigned / 
VFPL 475.2948 475.2915 6.94 +1 Collagen α-2(VI) chain  f(891-894) 






LxDLxLx 473.2962 473.2970 -1.69 +1 Various proteins / 
LPML 473.2762 473.2792 -6.34 +1 Myosin, light chain 1 
Myosin, light chain 3 
f(112-115) 
f(70-73) 
IGGLL 472.3088 472.3130 -8.89 +1 Titin* f(31419-29761) 
PSIVG 472.2801 472.2766 7.41 +1 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 







LxLxLxLx 471.3565 471.3541 5.09 +1 Various proteins / 




IKPL 470.3338 470.3337 0.21 +2 Myosin heavy chain f(839-842) 
KTVI 460.3135 460.3130 1.09 +1 Collagen α-1(I) chain  
Collagen α-1(II) chain  




IGGVI 458.2981 458.2973 1.75 +1 Fructose-bisphosphate 
aldolase B 
f(74-78) 
WPR 458.2437 458.2510 -15.93 +1 Not assigned / 
VLxLxLx 457.3410 457.3384 5.69 +1 Various proteins / 
LxLxGPG 456.2822 456.2817 1.10 +1 Not assigned / 
LxLxLxP 455.3247 455.3228 4.17 +1 Various proteins / 
VFPS 449.2347 499.2395 -10.68 +1 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 







LxAMLx 447.2608 447.2636 -6.26 +1 Various proteins / 
IGGSI 446.2654 446.2609 10.08 +1 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 












VLxLxV 443.3235 443.3228 1.58 +1 Various proteins / 
LxVLxV 443.3235 443.3228 1.58 +1 Various proteins / 
LxVVLx 443.3235 443.3228 1.58 +1 Various proteins / 




LxTPLx 443.2878 443.2864 3.16 +1 Various proteins / 
NVPI 442.2657 442.2660 -0.68 +1 Actin, α-skeletal 
muscle 
f(164-167) 
LxVLxP 441.3078 441.3071 1.59 +1 Various proteins / 
LxLxVP 441.3078 441.3071 1.59 +1 Various proteins / 
LxLxPV 441.3078 441.3071 1.59 +1 Various proteins / 
ALPH 437.2546 437.2507 8.92 +1 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 







FLxR 435.2697 435.2714 -3.91 +1 Various proteins / 
AIMV 433.2499    Collagen α-1(XIV) 
chain  
f(787-790) 
LxLxW 431.2671 431.2653 4.17 +1 Various proteins / 
VLPV 427.2914 427.2915 -0.23 +1 β-enolase f(144-147) 
WLxT 419.2307 419.2289 4.29 +1 Various proteins / 
LxSVV 417.2704 417.2708 -0.96 +1 Various proteins / 
VTVV 417.2704 417.2708 -0.96 +1 Various proteins / 
LxWV 417.2460 417.2496 -8.63 +1 Various proteins / 
VALxLx 415.2907 415.2915 -1.93 +1 Various proteins / 
PSIV 415.2581 415.2551 7.22 +1 Actin, cytoplasmic 1 
 
Actin, cytoplasmic 2 
 












LxAPLx 413.2765 413.2758 1.69 +1 Various proteins / 
LxALxP 413.2765 413.2758 1.69 +1 Various proteins / 
VALxT 403.2547 403.2551 -0.99 +1 Not assigned / 
GVLxLx 401.2760 401.2758 0.50 +1 Various proteins / 
VLxAV 401.2760 401.2758 0.50 +1 Various proteins / 










Collagen α-2(VI) chain 




LxGLxP 399.2603 399.2602 0.25 +1 Various proteins / 
AVLxP 399.2603 399.2602 0.25 +1 Various proteins / 
FLxLx 392.2571 392.2544 6.88 +1 Various proteins / 
LxLxF 392.2571 392.2544 6.88 +1 Various proteins / 
VVGLx 387.2595 387.2602 -181 +1 Various proteins / 
VGLxP 385.2435 385.2445 -2.60 +1 Collagen α-1(I) chain  
Collagen α-1(II) chain  
Collagen α-1(III) chain  
Collagen α-1(X) chain 
Collagen α-1(XIV) 
chain 
Collagen α-2(IX) chain  









LxLxM 376.2234 376.2265 -8.24 +1 Various proteins / 
LxFP 376.2234 376.2231 0.80 +1 Various proteins / 
PFLx 376.2234 376.2231 0.80 +1 Various proteins / 
LxPF 376.2234 376.2231 0.80 +1 Various proteins / 
FPLx 376.2234 376.2231 0.80 +1 Various proteins / 
FLxP 376.2234 376.2231 0.80 +1 Various proteins / 
GIW 375.2026 375.2027 -0.27 +1 Creatine kinase M-type 
Creatine kinase B-type 




LxQLx 373.2465 373.2445 5.36 +1 Various proteins / 
VPR 371.2453 371.2401 14.01 +1 Various proteins / 
LxVM 362.2148 362.2108 11.04 +1 Various proteins / 
FPV 362.2131 362.2074 15.74 +1 Various proteins / 
VPF 362.2131 362.2074 15.74 +1 Various proteins / 
LxVE 360.2057 360.2129 -19.99 +1 Various proteins / 
IGGL 359.2295 359.2289 1.67 +1 M-protein, striated 
muscle 
f(1335-1338) 
GLxLxG 359.2295 359.2289 1.67 +1 Various proteins / 




LxPK 357.2467 357.2496 -8.12 +1 Various proteins / 
LxTLx 346.2371 346.2336 10.11 +1 Various proteins / 
TLxLx 346.2371 346.2336 10.11 +1 Various proteins / 
VLxLx 344.2543 344.2544 -0.29 +1 Various proteins / 
LxLxV 344.2543 344.2544 -0.29 +1 Various proteins / 
LxPLx 342.2392 342.2387 1.46 +1 Various proteins / 
LxLxP 342.2392 342.2387 1.46 +1 Various proteins / 
AVF 336.1957 336.1918 11.60 +1 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 







FLxG 336.1957 336.1918 11.60 +1 Various proteins / 
WM 336.1370 336.1376 -1.78 +1 Various proteins / 
SLxLx 332.2125 332.2180 -16.56 +1 Various proteins / 
LxSLx 332.2125 332.2180 -16.56 +1 Various proteins / 
LxLxS 332.2125 332.2180 -16.56 +1 Various proteins / 
RR 331.2209 331.2201 2.42 +1 Various proteins / 
LxVV 330.2439 330.2387 15.75 +1 Various proteins / 
VLxV 330.2439 330.2387 15.75 +1 Various proteins / 
LxPV 328.2277 328.2231 14.01 +1 Various proteins / 
VLxP 328.2277 328.2231 14.01 +1 Various proteins / 
LxW 318.1807 318.1812 -1.57 +1 Various proteins / 
WLx 318.1807 318.1812 -1.57 +1 Various proteins / 
VW 304.1637 304.1656 -6.25 +1 Various proteins / 
LxGLx 302.2061 302.2074 -4.30 +1 Various proteins / 
FM 297.1249 297.1267 -6.06 +1 Various proteins / 
LxR 288.2023 288.2030 -2.43 +1 Various proteins / 




LxF 279.1679 279.1703 -8.60 +1 Various proteins / 
FV 265.1508 265.1547 -14.71 +1 Various proteins / 
LxM 263.1476 263.1424 19.76 +1 Various proteins / 
MLx 263.1476 263.1424 19.76 +1 Various proteins / 
PF 263.1339 263.1390 -14.06 +1 Various proteins / 
FP 263.1339 263.1390 -14.06 +1 Various proteins / 
LxLx 245.1818 245.1860 -17.13 +1 Various proteins / 
LxV 231.1722 231.1703 8.22 +1 Various proteins / 
VLx 231.1722 231.1703 8.22 +1 Various proteins / 
PLx 229.1507 229.1547 -17.46 +1 Various proteins / 
aMass are reported as monoisotopic.  
bPeptides were matched versus Gallus gallus proteins by using Peptide Match 
(https://research.bioinformatics.udel.edu/peptidematch/index.jsp#) 
*means that the peptide was identified in the corresponding human protein  






Table S5. Peptides identified in the <3 kDa permeate obtained from turkey meat after 








Charge Proteinb Fragment 




ALDPIDPPGKPVPL 1428.8194 1428.8097 6.79 +2 Titin* f(23921-23934) 
PEILPDGDHDLK 1348.6953 1348.6743 15.57 +3 Fructose-bisphosphate 
aldolase C 
f(189-200) 
VLDRPGPPEGPL 1246.6974 1246.6790 14.76 +2 Titin* f(24119-24130) 
f(27366-27377) 
SFDIPPPPMQS 1215.5936 1215.5714 18.26 +2 Phosphoglycerate 
mutase 
f(118-128) 
AVFPSIVGRPR 1198.7266 1198.7055 17.60 +3 Actin, cytoplasmic 1 






KDLFDPVIQD 1189.6210 1189.6099 9.33 +2 Creatine kinase M-type f(86-95) 




LVIIEGDLER 1156.6772 1156.6572 17.29 +2 Tropomyosin α-1 chain f(169-178) 
GDLGIEIPAEK 1141.6046 1141.6099 -4.64 +2 Pyruvate kinase f(294-304) 




LLTEAPLNPK 1095.6514 1095.6408 9.67 +2 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 







ALESPERPF 1045.5468 1045.5313 14.82 +2 Phosphoglycerate 
kinase 1 
f(200-208) 




LFDKPVSPL 1015.5944 1015.5823 11.91 +2 Creatine kinase M-type 
Creatine kinase B-type 




LTEAPLNPK 982.5690 982.5568 12.42 +2 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 







VDLPAVSEK 957.5388 957.5251 14.31 +2 Pyruvate kinase f(215-223) 











LxLxPLxEPELx 923.5556 923.5448 11.69 +2 Not assigned / 
MPGIGGSPGI 885.4608 885.4499 12.31 +1 Collagen α-1(IV) 
chain* 
f(1291-1300) 








LVPPSVEL 853.5176 853.5029 17.22 +2 Titin* f(20073-20080) 
KDLFDPV 833.4530 833.4403 15.24 +2 Creatine kinase M-type f(86-92) 




LTVLIGVP 811.5146 811.5288 -17.50 +2 Collagen α-1(XV) 
chain* 
f(43-50) 
IADLVVGL 799.4919 799.4924 -0.63 +1 β-enolase f(381-388) 
IIAPPER 795.4730 
 
795.4723 0.88 +2 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 







AVFPSIVG 789.4527 789.4505 2.79 +2 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 











VIGGLPDV 769.4471 769.4454 2.21 +1 M-protein, striated 
muscle 
f(1334-1341) 
DFGMDLA 768.3271 768.3233 4.95 +1 Myosin, heavy chain f(515-521) 
MYPGIAD 766.3475 
 
766.3440 4.57 +1 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 







EEFLPM 765.3634 765.3488 19.08 +2 Myosin, light chain 1 
Myosin, light chain 3 
f(109-114) 
f(67-72) 




VGVHLPQ 749.4400 749.4304 12.81 +2 Phosphoglycerate 
kinase 
f(177-183) 








741.4505 -15.24 +1 Derlin 1* f(20-27) 
VIPELNG 741.4242 
 




FLxESELx 737.3738 737.3716 2.98 +1 Not assigned / 
AVFPSIV 732.4310 732.4291 2.59 +1 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 







LILPVPA 722.4828 722.4811 2.35 +1 β-enolase f(143-149) 
GLxTALxELx 716.4093 716.4189 -13.40 +1 Not assigned / 
ISVPGPM 700.3715 700.3698 2.43 +1 Collagen α-1(I) chain f(174-180) 
EALxLxPR 698.4258 698.4196 8.88 +2 Not assigned / 
GVNLPGAA 698.3861 698.3832 4.15 +1 Pyruvate kinase f(207-214) 
DFGMDL 697.2901 697.2862 5.59 +1 Myosin, heavy chain f(515-520) 
MDLxVPLx 687.3769 687.3746 3.35 +1 Not assigned / 














ENLxPPLx 682.3845 682.3770 10.99 +1 Not assigned / 




VLPGVDA 670.3777 670.3770 1.04 +1 Phosphoglycerate 
kinase 1 
f(407-413) 
LAEIIT 659.4023 659.3974 7.43 +1 Myosin, heavy chain f(784-789) 
LxTLxTPLx 657.4141 657.4182 -6.24 +1 Not assigned / 
LANLIL 656.4367 656.4341 3.96 +1 Spastin f(321-326) 
PSLxLxLxLx 655.4375 655.4389 -2.14 +1 Not assigned / 





651.3171 6.60 +1 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 










RVDGFG 650.3175 650.3257 -12.61 +1 Not assigned / 
LGIHPL 649.4118 649.4032 13.24 +2 Lactate dehydrogenase 
A-chain 
f(178-183) 




TLVDVV 645.3749 645.3818 -10.69 +1 Lactate dehydrogenase 
A-chain 
f(49-54) 
LxDRLxAG 644.3629 644.3726 -15.05 +1 Not assigned / 
DIGLIL 643.4044 643.4025 2.95 +1 NADH-ubiquinone 
oxidoreductase chain 5 
f(180-185) 
LTEAPL 643.3677 643.3661 2.49 +1 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 







VQALxPLx 640.4052 640.4028 3.75 +1 Not assigned / 
IIAPPE 639.3725 
 
639.3712 2.03 +1 and 
+2 
Actin, cytoplasmic 1 
Actin, cytoplasmic 2 







EFLPM 636.3115 636.3062 8.33 +1 Myosin, light chain 1 
Myosin, light chain 3 
f(110-114) 
f(68-72) 
YGNPW 636.2798 636.2776 3.46 +1 Glycogen 
phosphorylase* 
f(186-190) 
SFIDF 628.3074 628.2977 15.44 +1 α-Actinin 2 f(842-846) 
VGPAPW 626.3332 626.3297 5.59 +1 PDZ and LIM domain 
protein 2* 
f(8-13) 
LALLVP 625.4285 625.4283 0.32 +1 Solute carrier family 46 
member 3 
f(448-453) 
LxKLxPF 617.4090 617.4021 11.18 +2 Titin* f(25241-25245) 
f(31974-31978) 
LTRLL 615.4071 615.4188 -19.01 +1 Kinesin-like protein 
KIF18B 
f(309-313) 
QLLEI 615.3743 615.3712 5.04 +1 Kinesin-like protein 
KIF18B 
f(207-211) 
LxDGVPLx 613.3661 613.3556 17.12 +1 and 
+2 
Not assigned / 
NGLVPI 612.3726 612.3715 1.79 +1 Fructose-bisphosphate 
aldolase B 
f(181-186) 
LLPVPA 609.4034 609.3970 10.50 +1 β-enolase f(144-149) 
LxLxVPPA 609.3990 609.3970 3.28 +1 Not assigned / 
NDIKN 603.3113 603.3097 2.65 +1 cAMP-dependent 






LDGDLA 603.3055 603.2984 11.77 +1 Creatine kinase B-
type* 
f(165-170) 
MPLxNK 602.3444 602.3330 18.93 +1 Not assigned / 
LxLxGNLxA 600.3770 600.3715 9.16 +1 Not assigned / 
VLPGVD 599.3412 599.3399 2.17 +1 Phosphoglycerate 
kinase 1 
f(407-412) 
LVIPF 588.3756 588.3756 0.00 +1 Myosin-binding protein 
C 
f(852-856) 
LxFVPI 588.3756 588.3756 0.00 +1 Titin* f(22807-22811) 
f(23889-23893) 




APIIAV 583.3853 583.3814 6.69 +1 Pyruvate kinase f(447-452) 
NISGW 576.2802 576.2776 4.51 +1 Myosin heavy chain f(592-596) 
NLGTGL 574.3213 574.3195 3.13 +1 Creatine kinase M-type 
Creatine kinase B-type 
Creatine kinase U-type 











ITEPI 572.3363 572.3290 12.75 +1 M-protein, striated 
muscle 
f(587-591) 
QVVLxLx 571.3830 571.3814 2.80 +1 Not assigned / 
LxELxVP 570.3509 570.3497 2.10 +1 Not assigned / 
VLxEPLx 570.3509 570.3497 2.10 +1 Not assigned / 
TVFPV 562.3276 562.3235 7.11 +1 Not assigned / 
IGGSIL 559.3480 559.3450 5.36 +1 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 







MVLPV 558.3364 558.3320 7.88 +1 β-enolase f(169-173) 
NLxLxPT 557.3299 557.3293 1.08 +1 Not assigned / 
LTIPI 556.3751 556.3705 8.27 +1 Titin* f(31083-31087) 
RLAPV 555.3597 555.3613 -2.88 +1 Titin* f(9402-9406) 
LxLxVLxP 554.3919 554.3912 1.26 +1 Not assigned / 




LxANLxLx 543.3524 543.3501 4.23 +1 Various proteins / 
LVTPL 542.3577 542.3548 5.35 +1 ATP dependent RNA 
helicase A 
f(1058-1062) 
ITLPV 542.3577 542.3548 5.35 +1 Phosphoglycerate 
kinase 1 
f(280-284) 
TPVLxLx 542.3577 542.3548 5.35 +1 Not assigned / 
DVLPV 542.3201 542.3184 3.32 +1 β-enolase* f(143-147) 
PSEPI 542.2901 542.2821 14.75 +1 Collagen α-1(XII) 
chain 
f(411-415) 
FIDF 541.2692 541.2657 6.47 +1 Myosin heavy chain f(513-516) 
LxDALxV 530.3210 530.3184 4.90 +1 Not assigned / 
IDILG 530.3110 530.3184 -13.95 +1 Myosin heavy chain f(339-343) 
ALLVI 528.3752 528.3756 -0.76 +1 Myosin-6* f(812-816) 




AIIPL 526.3576 526.3599 -4.37 +1 NADH-ubiquinone 
oxidoreductase chain 2 
f(39-43) 
AVFPS 520.2782 520.2766 3.08 +1 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 







VVIGM 518.3008 518.3007 0.19 +1 β-enolase f(240-244) 
RFPV 518.2985 518.3085 -19.29 +1 Serine/threonine-
protein kinase STK11 
f(147-150) 
GIITN 517.2970 517.2980 -1.93 +1 Actin, α-skeletal 
muscle 
f(76-80) 




LxALxVV 514.3545 514.3599 -10.50 +1 Not assigned / 
ADLxPV 514.2913 514.2871 8.17 +1 Not assigned / 
VPVVP 510.3304 510.3286 3.53 +1 Pyruvate carboxylase* f(164-168) 
VVPVP 510.3304 510.3286 3.53 +1 Pyruvate kinase f(526-530) 
LxAGGW 503.2631 503.2613 3.58 +1 Not assigned / 
LLGSI 502.3258 502.3235 4.58 +1 Myosin heavy chain f(748-752) 




VAVPL 498.3302 498.3286 3.21 +1 Derlin-1* f(23-27) 
FVEV 493.2665 493.2657 1.62 +1 Phosphoglycerate 
kinase 1 
f(324-327) 




INPF 490.2670 490.2660 2.04 +1 Titin* f(32371-32374) 
PFPQ 488.2599 488.2504 19.46 +1 Fructose-bisphosphate 
aldolase A* 
f(93-96) 
TVAPV 486.2892 486.2922 -6.17 +1 Not assigned / 
RGPVG 485.2838 485.2831 1.44 +2 Collagen α-1(IX) chain  
Collagen α-2(IX) chain  
f(505-509) 
f(391-395) 
RVPL 484.3151 494.3242 -18.79 +1 Sarcoplasmic/endoplas
mic reticulum calcium 
ATPase 1 
f(534-537) 
APIIA 484.3148 484.3130 3.72 +1 Titin* f(29757-29761) 
LxTFP 477.2718 477.2708 2.10 +1 Not assigned / 
VFPL 475.2947 475.2915 6.73 +1 Collagen α-2(VI) chain  f(891-894) 
GLLTA 474.2882 474.2922 -8.43 +1 Collagen α-1(XVII) 
chain  
f(1347-1351) 
LxDLxLx 473.2983 473.2970 2.75 +1 Various proteins / 
LPML 473.2783 473.2792 -1.90 +1 Myosin, light chain 1 
Myosin, light chain 3 
f(112-115) 
f(70-73) 
PSIVG 472.2772 472.2766 1.27 +1 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 







LxLxLxLx 471.3564 471.3541 4.88 +1 Various proteins / 




IKPL 470.3336 470.3337 -0.21 +2 Myosin heavy chain f(839-842) 
IGGVI 458.2983 458.2973 2.18 +1 Fructose-bisphosphate 
aldolase B 
f(74-78) 
WPR 458.2479 458.2510 -6.76 +1 Not assigned / 
VLxLxLx 457.3416 457.3384 7.00 +1 Various proteins / 
LxLxGPG 456.2831 456.2817 3.07 +1 Not assigned / 
LxLxLxP 455.3236 455.3228 1.76 +1 Various proteins / 
VFPS 449.2370 499.2395 -5.56 +1 Actin, cytoplasmic 1 











LxAMLx 447.2666 447.2636 6.71 +1 Various proteins / 
IGGSI 446.2623 446.2609 3.14 +1 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 












VLxLxV 443.3244 443.3228 3.61 +1 Various proteins / 
LxVLxV 443.3244 443.3228 3.61 +1 Various proteins / 
LxVVLx 443.3244 443.3228 3.61 +1 Various proteins / 
VLxVLx 443.3244 443.3228 3.61 +1 Various proteins / 
LxTPLx 443.2856 443.2864 -1.80 +1 Various proteins / 
NVPI 442.2643 442.2660 -3.84 +1 Actin, α-skeletal 
muscle 
f(164-167) 
LxVLxP 441.3082 441.3071 2.49 +1 Various proteins / 
LxLxVP 441.3082 441.3071 2.49 +1 Various proteins / 
LxLxPV 441.3082 441.3071 2.49 +1 Various proteins / 
ALPH 437.2462 437.2507 -10.29 +1 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 







LxTLxS 433.2721 433.2657 14.77 +1 Various proteins / 
AIMV 433.2473 433.2479 -1.38 +1 Collagen α-1(XIV) 
chain  
f(787-790) 
VLxLxS 431.2860 431.2864 -0.93 +1 Various proteins / 
VLPV 427.2923 427.2915 1.87 +1 β-enolase f(144-147) 




WLxT 419.2302 419.2289 3.10 +1 Various proteins / 
LxSVV 417.2703 417.2708 -1.20 +1 Various proteins / 




VALxLx 415.2907 415.2915 -1.93 +1 Various proteins / 
LxALxV 415.2907 415.2915 -1.93 +1 Various proteins / 
PSIV 415.2581 415.2551 7.22 +1 Actin, cytoplasmic 1 
 
Actin, cytoplasmic 2 
 












LxAPLx 413.2761 413.2758 0.73 +1 Various proteins / 
LxALxP 413.2761 413.2758 0.73 +1 Various proteins / 
VALxT 403.2512 403.2551 -9.67 +1 Not assigned / 
GVLxLx 401.2757 401.2758 -0.25 +1 Various proteins / 
VLxAV 401.2757 401.2758 -0.25 +1 Various proteins / 




Collagen α-2(VI) chain 







LxGLxP 399.2603 399.2602 0.25 +1 Various proteins / 
AVLxP 399.2603 399.2602 0.25 +1 Various proteins / 
LxLxF 392.2570 392.2544 6.63 +1 Various proteins / 
YPLx 392.2253 392.2180 18.61 +1 Various proteins / 
VGLxP 385.2416 385.2445 -7.53 +1 Collagen α-1(I) chain  
Collagen α-1(II) chain  
Collagen α-1(III) chain  
Collagen α-1(X) chain 
Collagen α-1(XIV) 
chain 
Collagen α-2(IX) chain  









VGPLx 385.2416 385.2445 -7.53 +1 Various proteins / 
TLxF 380.2165 380.2180 -3.94 +1 Various proteins / 
LxLxM 376.2237 376.2265 -7.44 +1 Various proteins / 
LxMLx 376.2237 376.2265 -7.44 +1 Various proteins / 




PFLx 376.2237 376.2231 1.59 +1 Various proteins / 
GIW 375.2035 375.2027 2.13 +1 Creatine kinase M-type 
Creatine kinase B-type 




LxQLx 373.2443 373.2445 -0.54 +1 Various proteins / 
VPR 371.2420 371.2401 5.12 +1 Various proteins / 
LxVM 362.2119 362.2108 3.04 +1 Various proteins / 
VMLx 362.2119 362.2108 3.04 +1 Various proteins / 
LxMV 362.2119 362.2108 3.04 +1 Various proteins / 
FPV 362.2119 362.2074 12.42 +1 Various proteins / 
LxVE 360.2057 360.2129 -19.99 +1 Various proteins / 
IGGL 359.2265 359.2289 -6.68 +1 M-protein, striated 
muscle 
f(1335-1338) 
GLxLxG 359.2265 359.2289 -6.68 +1 Various proteins / 
LxLxLx 358.2702 358.2700 0.56 +1 Various proteins / 
KPLx 357.2436 357.2496 -16.79 +1 Various proteins / 
LxTLx 346.2321 346.2336 -4.33 +1 Various proteins / 
LxLxT 346.2321 346.2336 -4.33 +1 Various proteins / 
TLxLx 346.2321 346.2336 -4.33 +1 Various proteins / 
VLxLx 344.2537 344.2544 -2.03 +1 Various proteins / 
LxLxV 344.2537 344.2544 -2.03 +1 Various proteins / 
LxVLx 344.2537 344.2544 -2.03 +1 Various proteins / 
LxPLx 342.2384 342.2387 -0.88 +1 Various proteins / 
LxLxP 342.2384 342.2387 -0.88 +1 Various proteins / 
AVF 336.1905 336.1918 -3.87 +1 Actin, cytoplasmic 1 
Actin, cytoplasmic 2 







FLxG 336.1905 336.1918 -3.87 +1 Various proteins / 
WM 336.1332 336.1376 -13.09 +1 Various proteins / 




LxSLx 332.2155 332.2180 -7.53 +1 Various proteins / 
LxLxS 332.2155 332.2180 -7.53 +1 Various proteins / 
VLxT 332.2155 332.2180 -7.53 +1 Various proteins / 
LxVT 332.2155 332.2180 -7.53 +1 Various proteins / 
LxVV 330.2389 330.2387 0.61 +1 Various proteins / 
VLxV 330.2389 330.2387 0.61 +1 Various proteins / 
LxPV 328.2220 328.2231 -3.35 +1 Various proteins / 
VLxP 328.2220 328.2231 -3.35 +1 Various proteins / 
LxW 318.1808 318.1812 -1.26 +1 Various proteins / 
WLx 318.1808 318.1812 -1.26 +1 Various proteins / 
VW 304.1651 304.1656 -1.64 +1 Various proteins / 
LxGLx 302.2030 302.2074 -14.56 +1 Various proteins / 
LxLxG 302.2030 302.2074 -14.56 +1 Various proteins / 
FM 297.1236 297.1267 -10.43 +1 Various proteins / 
FK 294.1869 294.1812 19.38 +1 Various proteins / 
FQ 295.1418 294.1448 -10.20 +1 Various proteins / 
LxR 288.2046 288.2030 5.55 +1 Various proteins / 
FLx 279.1664 279.1703 -13.97 +1 Various proteins / 
LxF 279.1664 279.1703 -13.97 +1 Various proteins / 
VF 265.1522 265.1547 -9.43 +1 Various proteins / 
FV 265.1522 265.1547 -9.43 +1 Various proteins / 
LxM 263.1449 263.1424 9.50 +1 Various proteins / 
FP 263.1355 263.1390 -13.30 +1 Various proteins / 
LxK 260.1959 260.1969 -3.84 +1 Various proteins / 
LxLx 245.1868 245.1860 3.26 +1 Various proteins / 




VLx 231.1702 231.1703 -0.43 +1 Various proteins / 
PLx 229.1531 229.1547 -6.98 +1 Various proteins / 
AH 227.1180 227.1139 18.05 +1 Various proteins / 
aMass are reported as monoisotopic.  
bPeptides were matched versus Gallus gallus proteins by using Peptide Match 
(https://research.bioinformatics.udel.edu/peptidematch/index.jsp#) 
*means that the peptide was identified in the corresponding human protein  





Table S6. Amino acids identified in the <3 kDa permeate obtained from pork, beef, 









W* 205.1073 205.0972 0.49 +1 P, B 
Y# 182.0808 182.0812 -2.20 +1 P, T 
R* 175.1158 175.1190 -18.27 +1 P, B  
F* 166.0885 166.0863 13.25 +1 P, B, C, T  
K* 147.1156 147.1128 19.03 +1 P, B, C, T 
Lx* 132.1014 132.1019 -3.78 +1 P, B, C, T 
T* 120.0646 120.0655 -7.50 +1 P 
V* 118.0842 118.0863 -17.78 +1 P, B  
aMass are reported as monoisotopic 
bSample in which the amino acid was identified (P: pork meat; B: beef meat; C: chicken meat; T: turkey 
meat)   
*Essential amino acids 
#Conditionally essential amino acids 
Lx indicates leucine or isoleucine 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 






